<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Machine perfusion in liver transplantation - Tingle, SJ - 2023 | Cochrane Library</title> <meta content="Machine perfusion in liver transplantation - Tingle, SJ - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014685.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Machine perfusion in liver transplantation - Tingle, SJ - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014685.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD014685.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Machine perfusion in liver transplantation" name="citation_title"/> <meta content="Samuel J Tingle" name="citation_author"/> <meta content="Newcastle University and Cambridge University" name="citation_author_institution"/> <meta content="samjamestingle@gmail.com" name="citation_author_email"/> <meta content="Joseph J Dobbins" name="citation_author"/> <meta content="Newcastle University" name="citation_author_institution"/> <meta content="Emily R Thompson" name="citation_author"/> <meta content="The Freeman Hospital" name="citation_author_institution"/> <meta content="Rodrigo S Figueiredo" name="citation_author"/> <meta content="The Freeman Hospital" name="citation_author_institution"/> <meta content="Balaji Mahendran" name="citation_author"/> <meta content="Royal Cornwall Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Sanjay Pandanaboyana" name="citation_author"/> <meta content="Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust" name="citation_author_institution"/> <meta content="Colin Wilson" name="citation_author"/> <meta content="The Freeman Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD014685.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/09/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014685.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014685.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014685.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*End Stage Liver Disease; *Liver Transplantation [adverse effects]; Perfusion; Quality of Life" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014685.pub2&amp;doi=10.1002/14651858.CD014685.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="fw9sVDQH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD014685\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD014685\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","th","ms","fa","id","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD014685.pub2",title:"Machine perfusion in liver transplantation",firstPublishedDate:"Sep 12, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hepato-Biliary Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=fw9sVDQH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014685.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD014685.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD014685.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD014685.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014685.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD014685.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;riskOfBias2&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of Bias&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD014685.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD014685.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD014685.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD014685.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2530 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD014685.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-sec-0043"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/appendices#CD014685-sec-0079"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2"> Risk of bias </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/supinfo/CD014685-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/supinfo/CD014685-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Machine perfusion in liver transplantation</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#CD014685-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Samuel J Tingle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#CD014685-cr-0005">Joseph J Dobbins</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#CD014685-cr-0006">Emily R Thompson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#CD014685-cr-0007">Rodrigo S Figueiredo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#CD014685-cr-0008">Balaji Mahendran</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#CD014685-cr-0009">Sanjay Pandanaboyana</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information#CD014685-cr-0010">Colin Wilson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information/en#CD014685-sec-0096">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 September 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD014685.pub2">https://doi.org/10.1002/14651858.CD014685.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD014685-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD014685-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD014685-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD014685-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD014685-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD014685-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD014685-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD014685-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD014685-abs-0001" lang="en"> <section id="CD014685-sec-0001"> <h3 class="title" id="CD014685-sec-0001">Background</h3> <p>Liver transplantation is the only chance of cure for people with end‐stage liver disease and some people with advanced liver cancers or acute liver failure. The increasing prevalence of these conditions drives demand and necessitates the increasing use of donated livers which have traditionally been considered suboptimal. Several novel machine perfusion preservation technologies have been developed, which attempt to ameliorate some of the deleterious effects of ischaemia reperfusion injury. Machine perfusion technology aims to improve organ quality, thereby improving outcomes in recipients of suboptimal livers when compared to traditional static cold storage (SCS; ice box). </p> </section> <section id="CD014685-sec-0002"> <h3 class="title" id="CD014685-sec-0002">Objectives</h3> <p>To evaluate the effects of different methods of machine perfusion (including hypothermic oxygenated machine perfusion (HOPE), normothermic machine perfusion (NMP), controlled oxygenated rewarming, and normothermic regional perfusion) versus each other or versus static cold storage (SCS) in people undergoing liver transplantation. </p> </section> <section id="CD014685-sec-0003"> <h3 class="title" id="CD014685-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 10 January 2023. </p> </section> <section id="CD014685-sec-0004"> <h3 class="title" id="CD014685-sec-0004">Selection criteria</h3> <p>We included randomised clinical trials which compared different methods of machine perfusion, either with each other or with SCS. Studies comparing HOPE via both hepatic artery and portal vein, or via portal vein only, were grouped. The protocol detailed that we also planned to include quasi‐randomised studies to assess treatment harms. </p> </section> <section id="CD014685-sec-0005"> <h3 class="title" id="CD014685-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were 1. overall participant survival, 2. quality of life, and 3. serious adverse events. Secondary outcomes were 4. graft survival, 5. ischaemic biliary complications, 6. primary non‐function of the graft, 7. early allograft function, 8. non‐serious adverse events, 9. transplant utilisation, and 10. transaminase release during the first week post‐transplant. We assessed bias using Cochrane's RoB 2 tool and used GRADE to assess certainty of evidence. </p> </section> <section id="CD014685-sec-0006"> <h3 class="title" id="CD014685-sec-0006">Main results</h3> <p>We included seven randomised trials (1024 transplant recipients from 1301 randomised/included livers). All trials were parallel two‐group trials; four compared HOPE versus SCS, and three compared NMP versus SCS. No trials used normothermic regional perfusion. </p> <p>When compared with SCS, it was uncertain whether overall participant survival was improved with either HOPE (hazard ratio (HR) 0.91, 95% confidence interval (CI) 0.42 to 1.98; P = 0.81, I<sup>2</sup> = 0%; 4 trials, 482 recipients; low‐certainty evidence due to imprecision because of low number of events) or NMP (HR 1.08, 95% CI 0.31 to 3.80; P = 0.90; 1 trial, 222 recipients; very low‐certainty evidence due to imprecision and risk of bias). </p> <p>No trials reported quality of life.</p> <p>When compared with SCS alone, HOPE was associated with improvement in the following clinically relevant outcomes: graft survival (HR 0.45, 95% CI 0.23 to 0.87; P = 0.02, I<sup>2</sup> = 0%; 4 trials, 482 recipients; high‐certainty evidence), serious adverse events in extended criteria DBD liver transplants (OR 0.45, 95% CI 0.22 to 0.91; P = 0.03, I<sup>2</sup> = 0%; 2 trials, 156 participants; moderate‐certainty evidence) and clinically significant ischaemic cholangiopathy in recipients of DCD livers (OR 0.31, 95% CI 0.11 to 0.92; P = 0.03; 1 trial, 156 recipients; high‐certainty evidence). In contrast, NMP was not associated with improvement in any of these clinically relevant outcomes. NMP was associated with improved utilisation compared with SCS (one trial found a 50% lower rate of organ discard; P = 0.008), but the reasons underlying this effect are unknown. </p> <p>We identified 11 ongoing studies investigating machine perfusion technologies.</p> </section> <section id="CD014685-sec-0007"> <h3 class="title" id="CD014685-sec-0007">Authors' conclusions</h3> <p>In situations where the decision has been made to transplant a liver donated after circulatory death or donated following brain death, end‐ischaemic HOPE will provide superior clinically relevant outcomes compared with SCS alone. Specifically, graft survival is improved (high‐certainty evidence), serious adverse events are reduced (moderate‐certainty evidence), and in donors after circulatory death, clinically relevant ischaemic biliary complications are reduced (high‐certainty evidence). There is no good evidence that NMP has the same benefits over SCS in terms of these clinically relevant outcomes. NMP does appear to improve utilisation of grafts that would otherwise be discarded with SCS; however, the reasons for this, and whether this effect is specific to NMP, is not clear. Further studies into NMP viability criteria and utilisation, as well as head‐to‐head trials with other perfusion technologies are needed. </p> <p>In the setting of donation following circulatory death transplantation, further trials are needed to assess the effect of these ex situ machine perfusion methods against, or in combination with, normothermic regional perfusion. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD014685-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD014685-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD014685-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD014685-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD014685-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/id#CD014685-abs-0013">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ko#CD014685-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD014685-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD014685-abs-0016">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD014685-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD014685-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD014685-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD014685-abs-0002" lang="en"> <h3>Can 'perfusion' machines improve the quality of livers donated for transplantation?</h3> <p><b>Key messages</b> </p> <p>– Cold machine perfusion improves liver transplantation when compared with the standard ice‐box technique. </p> <p>– Warm machine perfusion does not seem to have these benefits, but might allow the transplant of donated livers that would otherwise not be used. </p> <p><b>What is the issue?</b> </p> <p>Liver transplantation is the only chance of cure for thousands of people with liver failure or advanced liver cancers. Both of these conditions are becoming more common worldwide. This has caused an imbalance between the number of people needing a new liver, and the number of high‐quality livers which are donated. Increasingly, surgeons are driven to transplant livers which may be considered 'suboptimal'. Whilst receiving one of these livers is better than staying on the transplant waiting list, the outcomes are worse than with optimal organs. Many people are researching perfusion machines which pump liquid containing oxygen and nutrients through the liver in the time period between the death of the donor and the implant of the liver. These perfusion machines vary in lots of ways including the temperature that they keep the organ at. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to know which of these techniques is the best for improving the quality of donated livers. </p> <p><b>What did we do?</b> </p> <p>We performed a rigorous search for clinical trials which compared perfusion machines. We planned to include trials which compared perfusions machines with each other, or compared with standard ice‐box preservation. Our primary outcomes were death, quality of life, and serious side effects (serious adverse events). We also investigated secondary outcomes of how long the transplanted liver survived, bile duct (thin tubes that go from the liver to the small intestine) damage, and what proportion of the donated livers could be transplanted. </p> <p><b>What did we find?</b> </p> <p>We found six trials with 854 transplant recipients from 1124 donated livers.</p> <p><b>Main results</b> </p> <p>No machine was shown to reduce death, and no trials looked at quality of life. Compared with the standard ice‐box technique, cold machine perfusion improved the survival of the liver, reduced the number of serious adverse events, and reduced damage to the bile ducts. Warm machine perfusion with oxygen did not have these benefits. Warm machine perfusion appeared to increase the proportion of donated livers which could be transplanted, but more research is needed to understand why. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We found a limited number of trials and some were of mixed quality. The reported data were also insufficient for all planned analyses. None of the trials looked at a machine perfusion technique which is applied in the donor before the organs are removed (termed normothermic regional perfusion). </p> <p><b>How up to date is this evidence?</b><br/>The review includes studies published to 10 January 2023. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD014685-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD014685-sec-0074"></div> <h3 class="title" id="CD014685-sec-0075">Implications for practice</h3> <section id="CD014685-sec-0075"> <p>In situations where the decision has been made to transplant a liver donated following circulatory death (DCD) or an extended criteria liver donated following brainstem death (DBD) liver, end‐ischaemic hypothermic oxygenated machine perfusion (HOPE) will provide superior clinically relevant outcomes compared to static cold storage (SCS). Specifically, graft survival is improved (high‐certainty evidence), serious adverse events are reduced (moderate‐certainty evidence), and in DCD donors clinically relevant ischaemic biliary complications are reduced (high‐certainty evidence). </p> <p>There is no good evidence that NMP has the same benefits over SCS in terms of these clinically relevant outcomes. NMP appears to improve utilisation of grafts that would not otherwise be discarded with SCS, however, the reasons for this are not clear. There are no significant safety concerns relating to either HOPE or NMP. </p> </section> <h3 class="title" id="CD014685-sec-0076">Implications for research</h3> <section id="CD014685-sec-0076"> <p>Trials in donation following brainstem death (DBD) organ transplant are needed to directly compare various ex situ machine perfusion techniques, including novel techniques such as controlled oxygenated rewarming. A direct comparison of HOPE versus NMP is warranted, in addition to further randomised trials investigating alternative machine perfusion technologies, in isolation or in combination; such trials are ongoing (<a href="./references#CD014685-bbs2-0038" title="NCT04644744. Hypothermic oxygenated (HOPE) versus normothermic machine perfusion (NMP) in human liver transplantation. clinicaltrials.gov/ct2/show/NCT04644744 (first received 25 November 2020). ">NCT04644744</a>; <a href="./references#CD014685-bbs2-0039" title="NCT04744389. Comparison of hypothermic versus normothermic ex-vivo preservation. clinicaltrials.gov/show/NCT04744389 (first received 9 February 2021). ">NCT04744389</a>). In future machine perfusion studies of recipients of livers from extended criteria DBD donors end‐ischaemic HOPE should be used as the current gold standard 'control' (rather than SCS). </p> <p>In the setting of donation following circulatory death (DCD) transplantation, further trials are needed to assess the effect of ex situ machine perfusion devices against, or in combination with, normothermic regional perfusion. Randomised clinical trials are also needed to address remaining questions related to how NMP may improve graft utilisation, whether this effect is unique to NMP, or may be seen with other types of machine perfusion. In addition, further work refining, optimising, and validating NMP viability criteria is needed if they are to become widely adopted into clinical practice. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD014685-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD014685-sec-0008"></div> <div class="table" id="CD014685-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Hypothermic oxygenated perfusion (HOPE) compared with static cold storage (SCS) for preservation of livers prior to transplantation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypothermic oxygenated perfusion (HOPE) compared with static cold storage (SCS) for preservation of livers prior to transplantation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> liver transplant recipients </p> <p><b>Setting:</b> liver transplantation<br/><b>Intervention:</b> hypothermic oxygenated perfusion (HOPE)<br/><b>Comparison:</b> static cold storage (SCS) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with static cold storage (SCS)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with hypothermic oxygenated perfusion (HOPE)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overall participant survival</b><br/>follow‐up: median 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 0.91</b><br/>(0.42 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>482<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It is uncertain whether HOPE improves overall survival due to imprecision because of low numbers of deaths. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>940 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>945 per 1000</b><br/>(885 to 974) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> <p>follow‐up 90 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>449 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>426 per 1000</b><br/>(255 to 617) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.91</b><br/>(0.42 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HOPE reduces serious adverse events compared to SCS; however, the exact magnitude of this effect is unclear due to wide CIs. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Graft survival</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 0.45</b><br/>(0.23 to 0.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>482<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>HOPE improves graft survival compares to SCS alone.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>840 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>925 per 1000</b><br/>(859 to 961) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> total<br/>follow‐up: median 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b><br/>(14 to 88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.32</b><br/>(0.12 to 0.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>326<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In livers donated following circulatory death, HOPE reduces clinically significant ischaemic cholangiopathy compared to SCS alone. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> (donated following brain death (DBD)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/>(1 to 105) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.33</b><br/>(0.03 to 3.19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> (donated following circulatory death (DCD)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>64 per 1000</b><br/>(23 to 168) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.31</b><br/>(0.11 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early allograft dysfunction</b> </p> <p>total<br/>follow‐up: 7 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>398 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b><br/>(132 to 260) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.35</b><br/>(0.23 to 0.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>482<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HOPE reduces early allograft dysfunction compared to SCS alone. As peak post‐transplant transaminases contribute to this outcome, and there is a washout effect during perfusion, this outcome is of questionable clinical relevance. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events considered non‐serious</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>3 studies reported a lower number of total adverse events in the HOPE group compared with the SCS group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>312<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative synthesis could not be performed.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436878198874408136" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436878198874408136</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded two levels due to imprecision. <br/><sup>b</sup> Downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014685-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Normothermic machine perfusion (NMP) compared with static cold storage (SCS) for preservation of livers prior to transplantation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Normothermic machine perfusion (NMP) compared with static cold storage (SCS) for preservation of livers prior to transplantation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> liver transplant recipients<br/><b>Setting:</b> liver transplantation<br/><b>Intervention:</b> normothermic machine perfusion (NMP)<br/><b>Comparison:</b> static cold storage (SCS) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with static cold storage (SCS)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with normothermic machine perfusion (NMP)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overall participant survival</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 1.08</b><br/>(0.31 to 3.80) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>222<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It is uncertain whether NMP impacts overall participant survival.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>980 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>978 per 1000</b><br/>(926 to 994) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> (SAEs) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD014685-bbs2-0090" title="NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCD , et al. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6.">Nasralla 2018</a> reported 21 SAEs across 121 recipients of NMP livers, and 36 SAE across 101 recipients of SCS livers. <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> reported "liver specific" serious adverse event; 7/153 in the NMP group and 11/146 in the SCS group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>522<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP is not associated with an increase in SAEs compared with SCS; there are no safety concerns. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Graft survival</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 1.20</b><br/>(0.44 to 3.29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>522<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>NMP does not appear to improve graft survival compared to SCS.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>975 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>970 per 1000</b><br/>(920 to 989) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> (on protocol imaging)<br/>follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>86 per 1000</b><br/>(32 to 216) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.78</b><br/>(0.27 to 2.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP does not appear to reduce radiological ischaemic biliary complications, and the effect on clinically significant ischaemic biliary complications is not known. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early allograft dysfunction</b><br/>follow‐up: 7 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>146 per 1000</b><br/>(86 to 240) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.40</b><br/>(0.22 to 0.74) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>540<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP reduces early allograft dysfunction compared with SCS alone. As peak post‐transplant transaminases contribute to this outcome, and there is a washout effect during perfusion, this outcome is of questionable clinical relevance. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events considered non‐serious</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>574 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>554 per 1000</b><br/>(421 to 679) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.92</b><br/>(0.54 to 1.57) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>222<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP does not appear to reduce the proportion of recipients experiencing adverse events compared with SCS. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436879195689026772" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436879195689026772</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level due to risk of bias and two levels due to imprecision (because of low numbers of deaths). <br/><sup>b</sup> Downgraded two levels dues to risk of bias and imprecision. <br/><sup>c</sup> Downgraded one level due to risk of bias and two levels due to imprecision. <br/><sup>d</sup> Downgraded one level due to risk of bias; however, this bias may skew results in favour of SCS. <br/><sup>e</sup> Downgraded one level due to risk of bias; however, this may bias results in favour of SCS. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD014685-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD014685-sec-0009"></div> <section id="CD014685-sec-0010"> <h3 class="title" id="CD014685-sec-0010">Description of the condition</h3> <p>Liver transplantation is the only chance of cure for people with end‐stage liver disease and some people with advanced liver cancers or acute liver failure. Continuous advances in transplant medicine have resulted in excellent outcomes during recent years; the mean five‐year post‐liver transplantation survival is now around 80% in adults in the UK and USA (<a href="./references#CD014685-bbs2-0081" title="KwongA , KimWR , LakeJR , SmithJM , SchladtDP , SkeansMA , et al. OPTN/SRTR 2018 annual data report: liver. American Journal of Transplantation2020;20(Suppl S1):193-299.">Kwong 2020</a>; <a href="./references#CD014685-bbs2-0094" title="NHS Blood and Transplant. UK annual report on liver transplantation. nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-liver-transplantation-annual-report-2018-19.pdf (accessed 29 April 2020).">NHSBT 2019</a>). However, the lack of available organs results in significant mortality for those on the waiting list (<a href="./references#CD014685-bbs2-0081" title="KwongA , KimWR , LakeJR , SmithJM , SchladtDP , SkeansMA , et al. OPTN/SRTR 2018 annual data report: liver. American Journal of Transplantation2020;20(Suppl S1):193-299.">Kwong 2020</a>; <a href="./references#CD014685-bbs2-0094" title="NHS Blood and Transplant. UK annual report on liver transplantation. nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-liver-transplantation-annual-report-2018-19.pdf (accessed 29 April 2020).">NHSBT 2019</a>). In addition, many people who could receive a life‐saving transplant do not meet current inclusion criteria, as the precious and sparse resource of human organs is carefully allocated. </p> <p>Currently, approximately one‐third of retrieved organs in the UK do not proceed to transplant (<a href="./references#CD014685-bbs2-0094" title="NHS Blood and Transplant. UK annual report on liver transplantation. nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-liver-transplantation-annual-report-2018-19.pdf (accessed 29 April 2020).">NHSBT 2019</a>). Optimal liver grafts are donated following brainstem death (where warm ischaemic time is low) from standard criteria donors, who are younger than 50 years old, without hepatic steatosis or viral hepatitis (<a href="./references#CD014685-bbs2-0105" title="SaidiRF . Utilization of expanded criteria donors in liver transplantation. International Journal of Organ Transplantation Medicine2013;4(2):46-59.">Saidi 2013</a>). Recent attempts to expand the donor pool have resulted in the increasing use of suboptimal organs from expanded criteria donors, who are elderly; have hepatic steatosis, malignancies, or viral hepatitis; and those who donated following circulatory death (DCD) (<a href="./references#CD014685-bbs2-0105" title="SaidiRF . Utilization of expanded criteria donors in liver transplantation. International Journal of Organ Transplantation Medicine2013;4(2):46-59.">Saidi 2013</a>). However, it is well documented that these grafts have worse outcomes (both short‐term graft function and long‐term graft survival) if additional measures are not taken to improve preservation and optimise function of the liver transplant (<a href="./references#CD014685-bbs2-0044" title="BriceñoJ , CiriaR , PleguezueloM , dela MataM , MuntanéJ , Naranjo Á, et al. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transplantation2009;15(1):37-48.">Briceño 2009</a>; <a href="./references#CD014685-bbs2-0063" title="FoleyDP , FernandezLA , LeversonG , AndersonM , MezrichJ , SollingerHW , et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Annals of Surgery2011;253(4):817-25.">Foley 2011</a>; <a href="./references#CD014685-bbs2-0082" title="LaingRW , ScaleraI , IsaacJ , MergentalH . Liver transplantation using grafts from donors after circulatory death: a propensity score-matched study from a single center. American Journal of Transplantation2016;16(6):1795-804.">Laing 2016</a>; <a href="./references#CD014685-bbs2-0091" title="NemesB , GamanG , PolakWG , GelleyF , HaraT , OnoS , et al. Extended-criteria donors in liver transplantation part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. Expert Review of Gastroenterology &amp; Hepatology2016;10(7):841-59.">Nemes 2016</a>). </p> <p>DCD grafts pose a specific set of challenges, due to the damage brought on by warm ischaemia. This leads to a large increase in the prevalence of ischaemic biliary complications, which generally present in the first six months after transplant with obstructive jaundice and recurrent infection, often resulting in either retransplantation or death (<a href="./references#CD014685-bbs2-0065" title="GoussousN , Alvarez-CasasJ , DawanyN , XieW , MalikS , GraySH , et al. Ischemic cholangiopathy postdonation after circulatory death liver transplantation: donor hepatectomy time matters. Transplantation Direct2021;8(1):e1277.">Goussous 2021</a>; <a href="./references#CD014685-bbs2-0069" title="GuichelaarMM , BensonJT , MalinchocM , KromRA , WiesnerRH , CharltonMR . Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. American Journal of Transplantation2003;3(7):885-90.">Guichelaar 2003</a>). These ischaemic biliary complications have been termed the 'Achilles heel' of DCD liver transplantation (<a href="./references#CD014685-bbs2-0054" title="CroomeKP , TanerCB . The changing landscapes in DCD liver transplantation. Current Transplantation Reports2020;7(3):194-204.">Croome 2020</a>). </p> <p>Machine perfusion was first described nearly a century ago (<a href="./references#CD014685-bbs2-0060" title="DutkowskiP , deRougemontO , ClavienPA . Alexis Carrel: genius, innovator and ideologist. American Journal of Transplantation2008;8(10):1998-2003.">Dutkowski 2008</a>). There has been a resurgence of interest since the early 2000s, in the hope that machine perfusion could better preserve and optimise suboptimal grafts, thereby, improving graft and recipient survival following transplantation. Machine perfusion could also potentially allow some of the poorer quality retrieved livers, which currently are not used for transplantation, to be used, further expanding the donor pool (<a href="./references#CD014685-bbs2-0094" title="NHS Blood and Transplant. UK annual report on liver transplantation. nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-liver-transplantation-annual-report-2018-19.pdf (accessed 29 April 2020).">NHSBT 2019</a>). </p> </section> <section id="CD014685-sec-0011"> <h3 class="title" id="CD014685-sec-0011">Description of the intervention</h3> <p>It has long been known that reducing the temperature of organs can prolong their preservation time (<a href="./references#CD014685-bbs2-0053" title="CollinsGM , Bravo-ShugarmanM , TerasakiPI . Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet1969;2(7632):1219-22.">Collins 1969</a>). Clinically, this is achieved using a preservation solution to perfuse and surround the liver, which is then packaged in an ice box (termed 'static cold storage', SCS). This is a satisfactory method for preserving high‐quality liver grafts, which are reasonably resistant to ischaemia reperfusion injury. However, as the number of donors with expanded criteria and the number of organ donations after circulatory death have risen to try and match the demand for donor organs, there has been increased interest in alternative preservation methods, which may prove superior to standard SCS (<a href="./references#CD014685-bbs2-0081" title="KwongA , KimWR , LakeJR , SmithJM , SchladtDP , SkeansMA , et al. OPTN/SRTR 2018 annual data report: liver. American Journal of Transplantation2020;20(Suppl S1):193-299.">Kwong 2020</a>; <a href="./references#CD014685-bbs2-0094" title="NHS Blood and Transplant. UK annual report on liver transplantation. nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-liver-transplantation-annual-report-2018-19.pdf (accessed 29 April 2020).">NHSBT 2019</a>). </p> <p>Several machine perfusion technologies and strategies have been developed, which aim to improve organ preservation between donor and recipient, and optimise high‐risk grafts. These include normothermic machine perfusion (NMP), hypothermic oxygenated machine perfusion (HOPE), controlled oxygenated rewarming, and normothermic regional perfusion (<a href="./references#CD014685-bbs2-0061" title="DutkowskiP , SchlegelA , deOliveiraM , MullhauptB , NeffF , ClavienPA . HOPE for human liver grafts obtained from donors after cardiac death. Journal of Hepatology2014;60(4):765-72.">Dutkowski 2014</a>; <a href="./references#CD014685-bbs2-0062" title="DutkowskiP , PolakWG , MuiesanP , SchlegelA , VerhoevenCJ , ScaleraI , et al. First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis. Annals of Surgery2015;262(5):764-71.">Dutkowski 2015</a>; <a href="./references#CD014685-bbs2-0068" title='GuarreraJV , HenrySD , SamsteinB , ReznikE , MusatC , LukoseTI , et al. Hypothermic machine preservation facilitates successful transplantation of "orphan" extended criteria donor livers. American Journal of Transplantation2015;15(1):161-9.'>Guarrera 2015</a>; <a href="./references#CD014685-bbs2-0070" title="HessheimerAJ , CollE , TorresF , RuizP , GastacaM , RivasJI , et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. Journal of Hepatology2019;70(4):658-65.">Hessheimer 2019</a>; <a href="./references#CD014685-bbs2-0075" title="HoyerDP , MatheZ , GallinatA , CanbayAC , TreckmannJW , RauenU , et al. Controlled oxygenated rewarming of cold stored livers prior to transplantation: first clinical application of a new concept. Transplantation2016;100(1):147-52.">Hoyer 2016</a>; <a href="./references#CD014685-bbs2-0090" title="NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCD , et al. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6.">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0096" title="OniscuGC , RandleLV , MuiesanP , ButlerAJ , CurrieIS , PereraMT , et al. In situ normothermic regional perfusion for controlled donation after circulatory death – the United Kingdom experience. American Journal of Transplantation2014;14(12):2846-54.">Oniscu 2014</a>). The basic components of all of these perfusion circuits are a membrane oxygenator to deliver oxygen and remove carbon dioxide, a pump (which can provide continuous or pulsatile flow), a heater‐cooler unit, a reservoir, and infusion pumps. </p> <p>A detailed description of every proposed machine perfusion protocol is outside the scope of this current Cochrane Review, but has been recently reviewed (<a href="./references#CD014685-bbs2-0055" title="CziganyZ , LurjeI , TolbaRH , NeumannUP , TackeF , LurjeG . Machine perfusion for liver transplantation in the era of marginal organs – new kids on the block. Liver International2019;39(2):228-49.">Czigany 2019</a>). Perfusion can be performed in the donor during transportation of the organ from donor to recipient, or prior to implantation at the recipient hospital (end‐ischaemic). Some perfusions are normothermic, and some are hypothermic, but the exact target temperature used in different protocols varies. Hypothermic techniques/strategies can be completed without an oxygen carrier, whereas normothermic techniques/strategies require an oxygen carrier, which is often, but not always, human red blood cells (<a href="./references#CD014685-bbs2-0087" title="MattonAP , BurlageLC , vanRijnR , deVriesY , KarangwaSA , NijstenMW , et al. Normothermic machine perfusion of donor livers without the need for human blood products. Liver Transplantation2018;24(4):528-38.">Matton 2018</a>). </p> <p>Evidence from the kidney transplantation literature provides hope that machine perfusion may be able to improve clinical outcomes (<a href="./references#CD014685-bbs2-0121" title="TingleSJ , FigueiredoRS , MoirJA , GoodfellowM , TalbotD , WilsonCH . Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation. Cochrane Database of Systematic Reviews2019, Issue 3. Art. No: CD011671. [DOI: 10.1002/14651858.CD011671.pub2]">Tingle 2019</a>). In deceased donor renal transplantation, non‐oxygenated hypothermic machine perfusion (during transport) improved early function after kidney transplantation, and increased long‐term graft survival in organs procured after brain death (donated following brain death; DBD), and after circulatory death (DCD), when compared to SCS (<a href="./references#CD014685-bbs2-0121" title="TingleSJ , FigueiredoRS , MoirJA , GoodfellowM , TalbotD , WilsonCH . Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation. Cochrane Database of Systematic Reviews2019, Issue 3. Art. No: CD011671. [DOI: 10.1002/14651858.CD011671.pub2]">Tingle 2019</a>). </p> </section> <section id="CD014685-sec-0012"> <h3 class="title" id="CD014685-sec-0012">How the intervention might work</h3> <p>Traditional SCS aims to preserve transplant organs by lowering their metabolic rate. In general, for every 10 °C drop, the metabolism rate is halved (<a href="./references#CD014685-bbs2-0133" title="WilsonCH , BrookNR , TalbotD . Preservation solutions for solid organ transplantation. Mini Reviews in Medicinal Chemistry2006;6(10):1081-90.">Wilson 2006</a>). Therefore, at 4 °C, the enzymatic rate is approximately 10% of that at 37 °C (<a href="./references#CD014685-bbs2-0133" title="WilsonCH , BrookNR , TalbotD . Preservation solutions for solid organ transplantation. Mini Reviews in Medicinal Chemistry2006;6(10):1081-90.">Wilson 2006</a>). SCS works by removing blood and clots from the liver graft, and replacing them with an acellular preservation solution in a hypothermic environment. However, in this oxygen depletion system, metabolism does not completely halve. This results in adenosine triphosphate (ATP) depletion and ischaemic injury ensues, priming the graft for further reperfusion injury (<a href="./references#CD014685-bbs2-0086" title="MartinJL , CostaAS , GruszczykAV , BeachTE , AllenFM , PragHA , et al. Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation. Nature Metabolism2019;1(10):966-74.">Martin 2019</a>). </p> <p>Hypothermic oxygenated machine perfusion uses commercially available machines to deliver oxygenated perfusate while maintaining the principle of lowering metabolic activity through hypothermia. Protocols in current use describe end‐ischaemic HOPE in the recipient hospital (<a href="./references#CD014685-bbs2-0061" title="DutkowskiP , SchlegelA , deOliveiraM , MullhauptB , NeffF , ClavienPA . HOPE for human liver grafts obtained from donors after cardiac death. Journal of Hepatology2014;60(4):765-72.">Dutkowski 2014</a>; <a href="./references#CD014685-bbs2-0062" title="DutkowskiP , PolakWG , MuiesanP , SchlegelA , VerhoevenCJ , ScaleraI , et al. First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis. Annals of Surgery2015;262(5):764-71.">Dutkowski 2015</a>; <a href="./references#CD014685-bbs2-0068" title='GuarreraJV , HenrySD , SamsteinB , ReznikE , MusatC , LukoseTI , et al. Hypothermic machine preservation facilitates successful transplantation of "orphan" extended criteria donor livers. American Journal of Transplantation2015;15(1):161-9.'>Guarrera 2015</a>; <a href="./references#CD014685-bbs2-0126" title="vanRijnR , vanLeeuwenOB , MattonAP , BurlageLC , Wiersema-BuistJ , vanden HeuvelMC , et al. Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers. Liver Transplantation2018;24(5):655-64.">van Rijn 2018</a>). </p> <p>There are multiple proposed beneficial effects of performing HOPE. First, there is a physical washout benefit that helps to clear the microcirculation in the liver, which includes diluting waste products and blood remnants. The Porte Group, from the Netherlands, demonstrated that HOPE increased ATP content more than 15‐fold, which remained elevated after reperfusion (<a href="./references#CD014685-bbs2-0125" title="vanRijnR , KarimianN , MattonAP , BurlageLC , WesterkampAC , vanden BergAP , et al. Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death. British Journal of Surgery2017;104(7):907-17.">van Rijn 2017</a>; <a href="./references#CD014685-bbs2-0130" title="WesterkampAC , KarimianN , MattonAP , MahboubP , vanRijnR , Wiersema-BuistJ , et al. Oxygenated hypothermic machine perfusion after static cold storage improves hepatobiliary function of extended criteria donor livers. Transplantation2016;100(4):825-35.">Westerkamp 2016</a>). There also appears to be reduced expression of proinflammatory cytokines (<a href="./references#CD014685-bbs2-0111" title="SchlegelA , KronP , GrafR , ClavienPA , DutkowskiP . Hypothermic oxygenated perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. Annals of Surgery2014;260(5):931-7; discussion 937-8.">Schlegel 2014a</a>), downregulation of Kupffer cell activity (<a href="./references#CD014685-bbs2-0067" title="GuarreraJV , HenrySD , ChenSW , BrownT , NachberE , ArringtonB , et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. Journal of Surgical Research2011;167(2):e365-73.">Guarrera 2011</a>; <a href="./references#CD014685-bbs2-0109" title="SchlegelA , deRougemontO , GrafR , ClavienPA , DutkowskiP . Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts. Journal of Hepatology2013;58(2):278-86.">Schlegel 2013a</a>), and reduced vascular resistance (<a href="./references#CD014685-bbs2-0083" title="LeeCY , ZhangJX , Jones JW Jr, SouthardJH , ClemensMG . Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation2002;74(7):944-51.">Lee 2002</a>; <a href="./references#CD014685-bbs2-0098" title="Op den DriesS , SuttonME , KarimianN , deBoerMT , Wiersema-BuistJ , GouwAS , et al. Hypothermic oxygenated machine perfusion prevents arteriolonecrosis of the peribiliary plexus in pig livers donated after circulatory death. PLOS One2014;9(2):e88521.">Op den Dries 2014</a>). The delivery of oxygen, and recovery of mitochondria before restoration of normothermia (which is not achieved by NMP), is thought to be critical in preventing reperfusion injury (<a href="./references#CD014685-bbs2-0110" title="SchlegelA , GrafR , ClavienPA , DutkowskiP . Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation. Journal of Hepatology2013;59(5):984-91.">Schlegel 2013b</a>; <a href="./references#CD014685-bbs2-0112" title="SchlegelA , KronP , GrafR , DutkowskiP , ClavienPA . Warm vs. cold perfusion techniques to rescue rodent liver grafts. Journal of Hepatology2014;61(6):1267-75.">Schlegel 2014b</a>). </p> <p>NMP aims to maintain physiological conditions and a metabolically active liver by providing oxygen and nutrients. NMP replenishes liver ATP, and allows reperfusion to take place in a controlled environment, isolated from the recipient's immune and coagulation systems (<a href="./references#CD014685-bbs2-0045" title="BrockmannJ , ReddyS , CoussiosC , PigottD , GuirrieroD , HughesD , et al. Normothermic perfusion: a new paradigm for organ preservation. Annals of Surgery2009;250(1):1-6.">Brockmann 2009</a>; <a href="./references#CD014685-bbs2-0134" title="XuH , BerendsenT , KimK , Soto-GutiérrezA , BertheiumF , YarmushM , et al. Excorporeal normothermic machine perfusion resuscitates pig DCD livers with extended warm ischemia. Journal of Surgical Research2012;173(2):e83-8.">Xu 2012</a>). NMP can be performed in transit, therefore, avoiding ATP depletion and loss of metabolic homeostasis, which occurs with prolonged SCS (<a href="./references#CD014685-bbs2-0086" title="MartinJL , CostaAS , GruszczykAV , BeachTE , AllenFM , PragHA , et al. Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation. Nature Metabolism2019;1(10):966-74.">Martin 2019</a>; <a href="./references#CD014685-bbs2-0090" title="NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCD , et al. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6.">Nasralla 2018</a>). Finally, as NMP maintains a metabolically active organ, theoretically, it has benefits over hypothermic perfusion as a tool for viability assessment, and therefore, it could improve organ utilisation (<a href="./references#CD014685-bbs2-0088" title="MergentalH , PereraMT , LaingRW , MuiesanP , IsaacJR , SmithA , et al. Transplantation of declined liver allografts following normothermic ex-situ evaluation. American Journal of Transplantation2016;16(11):3235-45.">Mergental 2016</a>; <a href="./references#CD014685-bbs2-0129" title="WatsonCJ , KosmoliaptsisV , PleyC , RandleL , FearC , CrickK , et al. Observations on the ex situ perfusion of livers for transplantation. American Journal of Transplantation2018;18(8):2005-20.">Watson 2018</a>). </p> <p>Controlled oxygenated rewarming aims to capitalise on the aforementioned benefits of both HOPE and NMP, including early mitochondrial recovery and viability testing (<a href="./references#CD014685-bbs2-0128" title="vonHornC , BabaHA , HannaertP , HauetT , LeuveninkH , PaulA , et al. Controlled oxygenated rewarming up to normothermia for pretransplant reconditioning of liver grafts. Clinical Transplantation2017;31(11):e13101.">von Horn 2017</a>). Another key factor is the concept of rewarming injury. In animal models, the process of rapid rewarming (and resulting rapid increase in metabolic demands) has been shown to be detrimental (<a href="./references#CD014685-bbs2-0089" title="MinorT , vonHornC . Rewarming injury after cold preservation. International Journal of Molecular Sciences2019;20(9):2059.">Minor 2019</a>). In theory, controlled oxygenated rewarming allows early recovery of mitochondria, avoidance of rewarming injury, and maintenance of a metabolically active organ for prolonged preservation and viability testing. </p> <p>Normothermic regional perfusion in the donor is an alternative approach. Cannulae are placed to access the subdiaphragmatic aorta and inferior vena cava, and oxygenated blood is circulated through abdominal organs while they remain in situ. Animal models have shown that normothermic regional perfusion replenishes ATP and improves antioxidant levels (<a href="./references#CD014685-bbs2-0092" title="NetM , ValeroR , AlmenaraR , RullR , GonzalezFJ , TauraP , et al. Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs. Transplantation2001;71(9):1232-7.">Net 2001</a>; <a href="./references#CD014685-bbs2-0093" title="NetM , ValeroR , AlmenaraR , BarrosP , CapdevilaL , Lopez-BoadoMA , et al. The effect of normothermic recirculation is mediated by ischemic preconditioning in NHBD liver transplantation. American Journal of Transplantation2005;5(10):2385-92.">Net 2005</a>). Legislation in some countries allows cannulation and heparinisation of potential DCD donors premortem; in this setting, normothermic regional perfusion can greatly reduce warm ischaemic time (<a href="./references#CD014685-bbs2-0070" title="HessheimerAJ , CollE , TorresF , RuizP , GastacaM , RivasJI , et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. Journal of Hepatology2019;70(4):658-65.">Hessheimer 2019</a>). This is the only technique that is performed prior to in situ cold flush. Breaking the chain between perimortem warm ischaemia and cold ischaemia may lead to improved outcomes. </p> </section> <section id="CD014685-sec-0013"> <h3 class="title" id="CD014685-sec-0013">Why it is important to do this review</h3> <p>Several machine perfusion technologies have been developed which aim to improve utilisation and outcomes of donated livers. Improved techniques, which allow prolonged preservation, could also have logistical benefits and allow a shift towards operating in daylight hours. In addition, enabling longer preservation times could unlock the use of machine perfusion as a drug‐delivery platform to further optimise liver quality. </p> <p>Despite promising clinical data, it is unclear if machine perfusion functions better than SCS. It remains unclear which of these perfusion methods, and which perfusion protocols, result in the best clinical outcomes for the various types of available grafts. Trials often compare a new perfusion technique with standard static cold storage, with a lack of head‐to‐head comparisons amongst perfusion protocols. The use of network meta‐analysis would help to answer these questions. To our knowledge, there are no previous systematic reviews or network meta‐analyses of randomised clinical trials in liver machine perfusion. </p> <p>It is vital to analyse the data from randomised clinical trials to identify the impact of machine perfusion, and to compare different perfusion strategies, to establish the role of these techniques in clinical practice. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD014685-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD014685-sec-0014"></div> <p>To evaluate the effects of different methods of machine perfusion (including hypothermic oxygenated machine perfusion (HOPE), normothermic machine perfusion (NMP), controlled oxygenated rewarming, and normothermic regional perfusion) versus each other or versus static cold storage (SCS) in people undergoing liver transplantation. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD014685-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD014685-sec-0015"></div> <section id="CD014685-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD014685-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised clinical trials that compared preservation methods in deceased donor liver transplantation if at least one intervention group used machine perfusion. We anticipated that some trials would randomise at the recipient level, whereas some trials would randomise the liver graft itself into either intervention or control (especially those studies where perfusion was initiated at the donor hospital). We included both types of trials. We planned to include trials that fulfilled our inclusion criteria, even if they did not measure any of our outcomes of interest. We planned to use quasi‐randomised studies and observational studies for the report on harms (in a narrative way). </p> </section> <section id="CD014685-sec-0018"> <h4 class="title">Types of participants</h4> <section id="CD014685-sec-0019"> <h5 class="title">Inclusion criteria</h5> <p>Recipients of whole, deceased donor liver transplants from donors following either circulatory (DCD) or brain death (DBD). We planned to include trials of recipients of donors who met both standard criteria and expanded criteria (<a href="./references#CD014685-bbs2-0105" title="SaidiRF . Utilization of expanded criteria donors in liver transplantation. International Journal of Organ Transplantation Medicine2013;4(2):46-59.">Saidi 2013</a>). All adult recipients of liver transplants were eligible, including those receiving a retransplant. We included trials investigating liver utilisation proportions, which randomised liver grafts to a perfusion group; in this setting, the participant was the randomised donor liver. We also planned to include trials where only a subset of the participants were eligible; but no such trials were identified. We only included trials in humans. </p> </section> <section id="CD014685-sec-0020"> <h5 class="title">Exclusion criteria</h5> <p>We planned to exclude any studies with unethical retrieval of livers (<a href="./references#CD014685-bbs2-0077" title="International Summit on Transplant Tourism and Organ Trafficking. The declaration of Istanbul on organ trafficking and transplant tourism. Clinical Journal of the American Society of Nephrology2008;3(5):1227-31.">ISTTOT 2008</a>). Therefore, we assessed whether publications identified in our searches have since been withdrawn due to fraud or unethical organ retrievals. We excluded case series comparing perfusion techniques to retrospective cohorts. We excluded trials where grafts had been split or reduced, or used as part of a multivisceral transplant. We excluded preclinical studies investigating machine perfusion technologies where none of the grafts proceeded to transplant. </p> </section> </section> <section id="CD014685-sec-0021"> <h4 class="title">Types of interventions</h4> <p>Several machine perfusion technologies have been described, and any of these were eligible for inclusion. Specifically, we planned to compare the following methods: SCS (control), HOPE, NMP, controlled oxygenated rewarming, or normothermic regional perfusion. We expect that in the future, some trials may combine these techniques (e.g. normothermic regional perfusion followed by NMP). We grouped studies comparing HOPE via both hepatic artery and portal vein, or via portal vein only. </p> </section> <section id="CD014685-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We assessed outcomes at the maximum follow‐up, unless stated otherwise, for each of the following outcomes. </p> <section id="CD014685-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD014685-list-0001"> <li> <p>Overall participant survival</p> </li> <li> <p>Quality of life, assessed using any validated scale</p> </li> <li> <p>Serious adverse events. We accepted individual complications and serious adverse events defined by: </p> <ul id="CD014685-list-0002"> <li> <p>Clavien‐Dindo classification, grade III or higher (<a href="./references#CD014685-bbs2-0051" title="ClavienPA , BarkunJ , deOliveiraML , VautheyJN , DindoD , SchulickRD , et al. The Clavien-Dindo classification of surgical complications: five-year experience. Annals of Surgery2009;250:187-96.">Clavien 2009</a>; <a href="./references#CD014685-bbs2-0059" title="DindoD , DemartinesN , ClavienPA . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery2004;240:205-13.">Dindo 2004</a>); </p> </li> <li> <p>International Conference on Harmonization–Good Clinical Practice (ICH‐GCP) guideline: any untoward medical occurrences that resulted in death, were life‐threatening, required inpatient hospitalisation or prolongation of existing hospitalisation, and resulted in persistent or significant disability or incapacity (<a href="./references#CD014685-bbs2-0076" title="International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH). ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2). database.ich.org/sites/default/files/E6_R2_Addendum.pdf (accessed 10 December 2022).">ICH‐GCP 2016</a>). </p> </li> </ul> </li> </ul> </p> </section> <section id="CD014685-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD014685-list-0003"> <li> <p>Graft survival</p> </li> <li> <p>Ischaemic biliary complications, within six months and at maximum follow‐up (e.g. ischaemic‐type biliary lesions (<a href="./references#CD014685-bbs2-0063" title="FoleyDP , FernandezLA , LeversonG , AndersonM , MezrichJ , SollingerHW , et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Annals of Surgery2011;253(4):817-25.">Foley 2011</a>)) </p> </li> <li> <p>Primary non‐function of the graft</p> </li> <li> <p>Early allograft function, measured with a validated model (seven days) (e.g. Early Allograft Dysfunction or Model for Early Allograft Function criteria (<a href="./references#CD014685-bbs2-0080" title='JochmansI , FieuwsS , MonbaliuD , PirenneJ . "Model for early allograft function" outperforms "early allograft dysfunction" as a predictor of transplant survival. Transplantation2017;101(8):e258-64.'>Jochmans 2017</a>; <a href="./references#CD014685-bbs2-0095" title="OlthoffKM , KulikL , SamsteinB , KaminskiM , AbecassisM , EmondJ , et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transplantation2010;16(8):943-9.">Olthoff 2010</a>; <a href="./references#CD014685-bbs2-0101" title="ParejaE , CortesM , HervasD , MirJ , ValdiviesoA , CastellJV , et al. A score model for the continuous grading of early allograft dysfunction severity. Liver Transplantation2015;21(1):38-46.">Pareja 2015</a>)) </p> </li> <li> <p>Adverse events not considered serious by the aforementioned definitions</p> </li> <li> <p>Transplant utilisation (proportion of grafts allocated to an intervention that proceeded to transplant) </p> </li> <li> <p>Transaminase release during the first week post‐transplant (participant serum) (until seven days) </p> </li> </ul> </p> <p>We prespecified that we would not draw conclusions on the superiority of a perfusion technique based solely on outcomes such as early allograft dysfunction and transaminase release post‐transplant; these laboratory values are of questionable clinical relevance in machine perfusion studies, as proteins are washed out of the graft during machine perfusion. We have not included transaminase release in our summary of findings tables, and only discussed this outcome narratively. These outcomes are included as they have been used as the primary outcome in landmark machine perfusion trials (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>; <a href="./references#CD014685-bbs2-0090" title="NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCD , et al. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6.">Nasralla 2018</a>). Some clinicians consider these markers to be important in the field of liver machine perfusion, when trials powered for overall participant survival or graft survival are difficult to conduct. </p> <p>We also prespecified that we would not draw conclusions on the superiority of a technique based on graft utilisation, taken in isolation. We considered graft utilisation in the context of the outcomes in grafts that are transplanted. If a certain preservation technique increases graft utilisation while improving, or maintaining recipient outcomes, this is clearly of benefit. </p> </section> </section> </section> <section id="CD014685-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD014685-sec-0026"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Hepato‐Biliary Group (CHBG) Information Specialist searched the CHBG Controlled Trials Register via the Cochrane Register of Studies Web on 16 May 2022 and 10 January 2023. We searched the Cochrane Central Register of Controlled Trials (2022, Issue 5), MEDLINE Ovid (1946 to 10 January 2023), Embase Ovid (1974 to 10 January 2023), LILACS (Bireme; 1982 to 10 January 2023); Science Citation Index Expanded (Web of Science; 1900 to 10 January 2023); and Conference Proceedings Citation Index (Web of Science; 1990 to 10 January 2023). The latter two were searched simultaneously through the Web of Science. </p> <p><a href="./appendices#CD014685-sec-0080">Appendix 1</a> gives the search strategies with the date range of the searches. </p> </section> <section id="CD014685-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We searched the following online trial registries to identify ongoing and unpublished trials: ClinicalTrial.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>), European Medicines Agency (EMA; <a href="http://www.ema.europa.eu/ema/" target="_blank">www.ema.europa.eu/ema/</a>), World Health Organization International Clinical Trial Registry Platform (<a href="https://trialsearch.who.int/Default.aspx" target="_blank">trialsearch.who.int/Default.aspx</a>), and the US Food and Drug Administration (FDA; <a href="http://www.fda.gov" target="_blank">www.fda.gov</a>). </p> <p>We also searched the reference lists of relevant studies and clinical practice guidelines and searched the reference lists of recent reviews on liver machine perfusion (e.g. <a href="./references#CD014685-bbs2-0055" title="CziganyZ , LurjeI , TolbaRH , NeumannUP , TackeF , LurjeG . Machine perfusion for liver transplantation in the era of marginal organs – new kids on the block. Liver International2019;39(2):228-49.">Czigany 2019</a> and <a href="./references#CD014685-bbs2-0113" title="SchlegelA , MullerX , DutkowskiP . Machine perfusion strategies in liver transplantation. Hepatobiliary Surgery and Nutrition2019;8(5):490-501.">Schlegel 2019</a>). </p> </section> </section> <section id="CD014685-sec-0028"> <h3 class="title" id="CD014685-sec-0028">Data collection and analysis</h3> <p>We performed this review in line with recommendations from the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014685-bbs2-0071" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021a</a>). </p> <section id="CD014685-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two review authors (ST and JD) independently screened titles identified by our search strategy. We discarded reports that did not fulfil the inclusion criteria of this review; however, initially, we retained reports of studies and reviews that may have included relevant data or references to relevant trials. Two review authors (ST and JD) then independently assessed retrieved abstracts, and if necessary, the full text of these studies to determine which studies satisfied the inclusion criteria. One review author (CW) was available to resolve any differences in opinion around trial selection, but there were none. </p> <p>Where multiple publications existed for a single randomised clinical trial, we listed all of them under a single, main study reference. We also planned to include trials that were only available as conference abstracts. We planned to include trials in the review, regardless of whether measured outcome data were reported in a usable way, only if we could ensure that these studies were not withdrawn because of ethical or other reasons. A PRISMA flowchart was generated to detail the output of our search and study selection (<a href="./references#CD014685-bbs2-0099" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n71.">Page 2021a</a>; <a href="./references#CD014685-bbs2-0100" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n160.">Page 2021b</a>). </p> </section> <section id="CD014685-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (ST and JD) independently extracted necessary data from the included trials, using a prepiloted data extraction form. This included information on trial characteristics, included participants, type(s) of machine perfusion, additional potential effect modifiers, outcome data (including measurement time point), and source of funding. We planned to resolve any discrepancies with the senior review author (CW). </p> </section> <section id="CD014685-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ST and JD) independently assessed risk of bias, and where differences of opinion arose, CW arbitrated. We used the Cochrane RoB 2 tool, as outlined in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014685-bbs2-0072" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021b</a>). </p> <p>We assessed the effect of assignment to the intervention using RoB 2 (<a href="./references#CD014685-bbs2-0072" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021b</a>). Therefore, we performed analyses based on the intention‐to‐treat (ITT) principle, which includes all randomised participants, regardless of the interventions that participants actually received. </p> <p>In brief, we assessed the following sources of bias in the individually randomised trials, at the outcome level, using RoB 2 (<a href="./references#CD014685-bbs2-0072" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021b</a>; <a href="./references#CD014685-bbs2-0117" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Research Ed.)2019;366:l4898.">Sterne 2019</a>). </p> <p> <ul id="CD014685-list-0004"> <li> <p>Bias arising from the randomisation process</p> </li> <li> <p>Bias due to deviations from intended interventions</p> </li> <li> <p>Bias due to missing outcome data</p> </li> <li> <p>Bias in measurement of the outcome</p> </li> <li> <p>Bias in selection of the reported result</p> </li> </ul> </p> <p>As per the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> guidance, we used RoB 2 to assess the risk of bias for only a subset of outcomes (<a href="./references#CD014685-bbs2-0072" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021b</a>). There is currently no guidance on how to select outcomes for which to perform risk of bias assessments; we have selected outcomes based on the most contemporaneous advice from Cochrane. The risk of bias assessments fed into one domain of the GRADE approach for assessing certainty of a body of evidence (<a href="./references#CD014685-bbs2-0115" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Schünemann 2021</a>). For the risk of bias assessment, we focussed on results of the trials that contributed information that users of the review will find most useful; overall participant survival at maximum follow‐up, quality of life, serious adverse events, graft survival, ischaemic biliary complications (ischaemic‐type biliary lesions) within one year, and adverse events considered non‐serious. </p> <p>We carefully studied the latest (i.e. at the time of review production) guidance on preliminary consideration for assessing risk of bias, the signalling questions to be used, and the response options for the signalling questions, such as yes, probably yes, no, probably no, and no information (<a href="./references#CD014685-bbs2-0072" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021b</a>; <a href="./references#CD014685-bbs2-0117" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Research Ed.)2019;366:l4898.">Sterne 2019</a>). </p> <section id="CD014685-sec-0032"> <h5 class="title">Overall risk of bias</h5> <p>The overall rating assigns one of three levels of judgement:</p> <p> <ul id="CD014685-list-0005"> <li> <p>low risk of bias: the trial was at low risk of bias for all domains for this result;</p> </li> <li> <p>some concerns: the trial was judged to raise some concerns in at least one domain for this result, but was not at high risk of bias for any of the remaining domains; </p> </li> <li> <p>high risk of bias: the trial was at high risk of bias in at least one domain for this result, or the study was judged to have some concerns for multiple domains in a way that substantially lowered confidence in the result. </p> </li> </ul> </p> <p>We used the same levels of overall risk of bias judgements across different trials for each of the domains listed as we used for the individual domains, that is low risk of bias, some concerns, or high risk of bias. Judging a result to be at a particular level of risk of bias for an individual domain implied that the result has an overall risk of bias at least this severe. We followed the guidance on preliminary consideration for assessing risk of bias on how to record risk of bias in trial data obtained through different sources (e.g. unpublished data, correspondence with a trialist, etc.). </p> </section> <section id="CD014685-sec-0033"> <h5 class="title">Displaying risk of bias judgements</h5> <p>We used the most recently developed <a href="https://www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2" target="_blank">RoB 2 Excel tool</a>. An algorithm in Excel maps the responses to the signalling questions per outcome, and proposes a risk of bias judgement for each domain. We stored the Excel spreadsheets for each trial outcome on a secure server, which are available upon request. In the most up‐to‐date version of Review Manager Web at the time of writing (<a href="./references#CD014685-bbs2-0104" title="Review Manager Web (RevMan Web). Version 1.22.0. The Cochrane Collaboration, 2020. Available at: revman.cochrane.org.">RevMan Web 2020</a>), RoB 2 assessments (and their justifications) are only visible if a trial is included in the 'analysis' section for that outcome. Therefore, where only one trial gives usable data for an outcome or interest, a forest plot and analysis has still been generated in order to include RoB 2 assessments and their justifications. </p> </section> </section> <section id="CD014685-sec-0034"> <h4 class="title">Measures of treatment effect</h4> <p>We used odds ratios (OR) with 95% confidence intervals (CI) for dichotomous outcomes. We analysed participant survival and graft survival as time‐to‐event data, and performed meta‐analysis using the general inverse‐variance method, as described in Chapter 10 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014685-bbs2-0057" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Deeks 2021</a>). Where hazard ratios (HR) were not available, we used techniques described by <a href="./references#CD014685-bbs2-0120" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials2007;8(1):16.">Tierney 2007</a> to estimate HRs, in line with guidance from the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014685-bbs2-0073" title="HigginsJP , LiT , DeeksJJ . Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021c</a>). </p> <p>For quality of life, we planned to pool the results using standardised mean difference (SMD) with 95% CI. However, no trials reported on this outcome. </p> </section> <section id="CD014685-sec-0035"> <h4 class="title">Unit of analysis issues</h4> <p>We anticipated that included trials would randomise either at the level of the transplant recipient or at the level of the liver graft. For trials randomising transplant recipients, we did not foresee any unit of analysis issues. For trials randomising liver grafts and reporting on graft utilisation, the unit of analysis was the liver grafts for this outcome. Such trials also reported on recipient outcomes; in this case, the unit of analysis was the transplant recipient. We did not expect cluster or cross‐over trials, and none were found. We analysed the results using ITT analysis wherever possible. </p> </section> <section id="CD014685-sec-0036"> <h4 class="title">Dealing with missing data</h4> <p>Our preferred method of dealing with missing data was to contact trial authors and attempt to obtain missing data from them directly. When this failed, we planned to impute missing data using methods outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (e.g. last observation carried forward; imputing an assumed outcome, such as assuming all were poor outcomes; imputing the mean; imputing based on predicted values from a regression analysis (<a href="./references#CD014685-bbs2-0074" title="HigginsJP , EldridgeS , LiT . Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021d</a>)). We planned to select an imputation method depending on the data available; if multiple methods were appropriate, we planned to perform sensitivity analyses with each. </p> <p>For missing standard deviations, we planned to impute these from P values, 95% CIs, or from other studies with similar designs, participant groups, and numbers (<a href="./references#CD014685-bbs2-0064" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7-10.">Furukawa 2006</a>). As described above, we analysed survival as time‐to‐event data. In all cases, this could be performed directly using HRs, or estimating these using the available time‐to‐event analyses (such as number of events and P values from logrank tests) using methods described by <a href="./references#CD014685-bbs2-0120" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials2007;8(1):16.">Tierney 2007</a>. </p> </section> <section id="CD014685-sec-0037"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical and methodological heterogeneity as described in <a href="#CD014685-sec-0040">Subgroup analysis and investigation of heterogeneity</a>. We visually assessed heterogeneity using forest plots generated from pairwise comparison meta‐analyses. We paid particular attention to the following potential effect modifiers when assessing heterogeneity: DCD compared to DBD, expanded criteria donors compared to standard criteria donors, steatotic grafts, age of donors, duration of cold ischaemic time or perfusion time, type of perfusion fluid used, and recipient factors (age, indication, retransplant). For most of these, there was an insufficient number of trials to perform meaningful subgroup analyses. </p> <p>Then, we analysed the presence and extent of heterogeneity using the standard I² statistic (the percentage of the variability in effect estimates that was due to heterogeneity rather than chance). Strict cut‐offs for the I² statistic are often not useful, especially in this review where the number of trials for each comparison was low (making the Chi² test, which underlies the I² statistic, underpowered). However, we used the following thresholds as a guide (<a href="./references#CD014685-bbs2-0057" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Deeks 2021</a>): </p> <p> <ul id="CD014685-list-0006"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD014685-sec-0038"> <h4 class="title">Assessment of reporting biases</h4> <p>As there were fewer than 10 trials in the analysis, funnel plots could not be used to assess for small‐study bias (<a href="./references#CD014685-bbs2-0071" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021a</a>). </p> </section> <section id="CD014685-sec-0039"> <h4 class="title">Data synthesis</h4> <p>We performed all data analyses following instructions from the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014685-bbs2-0071" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021a</a>). For pairwise analyses, we used Review Manager Web (<a href="./references#CD014685-bbs2-0104" title="Review Manager Web (RevMan Web). Version 1.22.0. The Cochrane Collaboration, 2020. Available at: revman.cochrane.org.">RevMan Web 2020</a>). If meta‐analysis was not possible, we planned to use alternative methodologies to report results, but these were not required. </p> <p>We performed individual pairwise meta‐analyses when there was direct evidence from at least two trials comparing the same preservation techniques. We performed this using random‐effects models for our main analyses. We used the methods of <a href="./references#CD014685-bbs2-0048" title="BucherHC , GuyattGH , GriffithLE , WalterSD . The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology1997;50(6):683-91.">Bucher 1997</a>, which are endorsed by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014685-bbs2-0049" title="ChaimaniA , CaldwellDM , LiT , HigginsJP , SalantiG . Chapter 11: Undertaking network meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Chaimani 2021</a>), to perform an indirect comparison between two machine perfusion techniques (HOPE and NMP), where the only trials available compared them to a common control preservation technique (SCS). </p> </section> <section id="CD014685-sec-0040"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform the following subgroup analyses; however, sufficient data were rarely available to allow this. </p> <p> <ul id="CD014685-list-0007"> <li> <p>Trials at overall low risk of bias compared to trials with some concerns, and trials at high risk of bias, as trials with some concern and at high risk of bias may overestimate or underestimate the intervention effects (<a href="./references#CD014685-bbs2-0072" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021b</a>). </p> </li> <li> <p>Trials without for‐profit funding compared to trials with some concern or at risk of for‐profit funding, as conflicts of interest can introduce bias, including publication bias (<a href="./references#CD014685-bbs2-0085" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>). </p> </li> <li> <p>Donation following circulatory death (stratified by Maastricht criteria) compared to donation following brainstem death, as these grafts have different patterns of ischaemic injury, and therefore, treatment effects may vary (<a href="./references#CD014685-bbs2-0119" title="ThuongM , RuizA , EvrardP , KuiperM , BoffaC , AkhtarMZ , et al. New classification of donation after circulatory death donors definitions and terminology. Transplant International2016;29(7):749-59.">Thuong 2016</a>). </p> </li> <li> <p>Standard criteria donors compared to extended criteria donors, as standard criteria organs may be more resilient to ischaemia reperfusion injury, meaning preservation effects may vary; this was not possible as they either included only extended criteria, or did not give separate results for standard versus extended criteria donors. </p> </li> <li> <p>Continuous perfusion during transport compared to perfusion at the recipient centre (end‐ischaemic), as the prior cold ischaemic time in the latter group may alter treatment effect size; this was not possible as all HOPE trials were end‐ischaemic, and all non‐pilot NMP trials were continuous. </p> </li> </ul> </p> <p>We assessed statistical heterogeneity as described above. We planned to perform this assessment for the overall cohort, and within each subgroup, providing insights into the source of any heterogeneity present. However, due to the small number of trials such analyses were either not possible, or would be meaningless due to very low statistical power. </p> </section> <section id="CD014685-sec-0041"> <h4 class="title">Sensitivity analysis</h4> <p>We assessed the sensitivity of our results to changes in methodology, by performing the following sensitivity analyses of our outcome measures. </p> <p> <ul id="CD014685-list-0008"> <li> <p>Fixed‐effect model (for pairwise meta‐analyses)</p> </li> <li> <p>Including only trials at low risk of bias; this was not possible as meta‐analyses either included only trials at low risk of bias, or no trials at low risk of bias </p> </li> <li> <p>Analyses excluding trials for which we imputed data</p> </li> </ul> </p> </section> <section id="CD014685-sec-0042"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created two summary of findings tables on two comparisons (i.e. HOPE versus SCS for liver transplant recipients and NMP versus SCS for liver transplant recipients). We presented the following outcomes: overall participant survival at maximum follow‐up, quality of life, serious adverse events, graft survival, ischaemic biliary complications (within six months), early allograft dysfunction (seven days), and adverse events considered non‐serious. We included these outcomes in the summary of findings tables even if there were no data available. We used the five GRADE factors (i.e. risk of bias, inconsistency, imprecision, indirectness, and publication bias) to assess the certainty of evidence as it related to the trials that contributed data for the prespecified outcomes (<a href="./references#CD014685-bbs2-0114" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html (accessed 10 December 2022).">Schünemann 2013</a>). </p> <p>Regarding 'risk of bias', we used the overall judgement for an outcome result. 'Low' risk of bias indicates 'no limitation (the certainty is not rated down)'; 'Some concerns' indicates either 'no limitation' or 'serious limitation (the certainty is rated down one level)'; and 'High' risk of bias indicates either 'serious limitation' or 'very serious limitation (the certainty is rated down two levels)'. </p> <p>We used the methods and recommendations described in Chapter 14 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD014685-bbs2-0115" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Schünemann 2021</a>), using GRADEpro GDT software (<a href="./references#CD014685-bbs2-0066" title="GRADEpro GDT. Version accessed 4 July 2021. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.">GRADEpro GDT</a>). We justified all decisions to downgrade the certainty of evidence using footnotes, and made comments to aid the reader's understanding of the review where necessary. </p> <p>We assessed the certainty of evidence as falling into one of these levels of evidence.</p> <p> <ul id="CD014685-list-0009"> <li> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>Two review authors (ST and JD) independently assessed the certainty of evidence, and disagreements were resolved by a third review author (CW). Next to each outcome in the summary of findings tables, we have provided the duration of the analysed follow‐up data (including its mean and range where possible). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD014685-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD014685-sec-0043"></div> <section id="CD014685-sec-0044"> <h3 class="title">Description of studies</h3> <section id="CD014685-sec-0045"> <h4 class="title">Results of the search</h4> <p>The database searches identified 2502 records and clinical trial registries identified 179 records on 16 May 2022 and 10 January 2023 (<a href="#CD014685-fig-0001">Figure 1</a>). After exclusion of duplicates, we screened 2493 records and excluded 2406 records based on title and abstract. We retrieved the full text of the remaining 87 records and assessed them for eligibility. We excluded 22 trials (32 records) with reason for exclusion (<a href="./references#CD014685-sec-0103" title="">Characteristics of excluded studies</a> table) and identified 11 ongoing studies (19 reports) investigating machine perfusion technologies (<a href="./references#CD014685-sec-0105" title="">Characteristics of ongoing studies</a> table). Overall, seven trials were included in the review, comprising 34 individual reports (<a href="./references#CD014685-sec-0102" title="">Characteristics of included studies</a> table). One study (two records) is awaiting classification (<a href="./references#CD014685-sec-0104" title="">Characteristics of studies awaiting classification</a> table). </p> <div class="figure" id="CD014685-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow diagram for the identification of included studies in the meta‐analysis of machine perfusion in liver transplantation (Page 2021a; Page 2021b). Date of last search 10 January 2023." data-id="CD014685-fig-0001" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram for the identification of included studies in the meta‐analysis of machine perfusion in liver transplantation (<a href="./references#CD014685-bbs2-0099" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n71.">Page 2021a</a>; <a href="./references#CD014685-bbs2-0100" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n160.">Page 2021b</a>). Date of last search 10 January 2023. </p> </div> </div> </div> <p>Our search identified no quasi‐randomised studies or observational studies which would add additional information on intervention harms to the review. </p> </section> <section id="CD014685-sec-0046"> <h4 class="title">Included studies</h4> <p>Full details for the seven included trials are available in the <a href="./references#CD014685-sec-0102" title="">Characteristics of included studies</a> table. These seven trials included 1024 transplant recipients from 1301 randomised/included livers. Trials were completed in Europe (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>) or the US (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>). </p> <p>All were two‐arm randomised clinical trials comparing a machine perfusion technique with SCS. Two large trials (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>) and one pilot trial (<a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>) compared NMP with SCS. The other four trials compared HOPE with SCS (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). No trials used normothermic regional perfusion, all DCD retrievals used the standard super rapid retrieval technique. Machines used for NMP were the OrganOx Metra (<a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>), Liver Assist from Organ Assist (<a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>), and the Transmedics portable Organ Care System Liver device (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>); all of these performed oxygenated perfusions at 37 °C with a blood‐based perfusate. Machines used for HOPE were the Liver Assist from Organ Assist (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>) and the Bridge to Life Vitasmart (<a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>). </p> <p>All trials of HOPE performed this as an end‐ischaemic intervention, in the recipient hospital (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> perfused both the hepatic artery and portal vein (sometimes termed dual HOPE), whereas <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>, <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>, and <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> perfused only the portal vein. The two largest NMP trials initiated NMP in the donor hospital and continued throughout transport (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>), whereas the pilot trial investigated end‐ischaemic NMP (<a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>). </p> <p>SCS was generally performed according to pre‐established local protocols, as this treatment is the current standard of care. Regarding NMP versus SCS trials: <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> used either University of Wisconsin solution (UW) or histidine‐tryptophan‐ketoglutarate (HTK) as the SCS solution, <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> used Celsior solution, and <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> did not specify the cold storage solution used. The SCS solution used in HOPE versus SCS trials was either HTK (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>), UW (<a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>), Celsior solution (<a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>), or Institut Georges Lopez solution (IGL‐1) (<a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>). </p> <p>Median total preservation times ranged from 5 hours and 38 minutes to 11 hours and 54 minutes (further details in <a href="./references#CD014685-sec-0102" title="">Characteristics of included studies</a> table). The longest total preservation times were achieved in the NMP arm of <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>. </p> <p>Trials included: only DCD livers (<a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>), only DBD donors (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>), or a mix of the two (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>). Trials including DBD livers typically restricted to only expanded criteria donors (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>), whereas <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> and <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> also included standard criteria DBD and <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> selected livers with a moderate risk profile. </p> <p>As detailed in our protocol, we emailed trial authors for clarification where needed. This was only required for <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>, who kindly provided raw data on graft survival and mortality to allow them to be analysed as time‐to‐event variables. </p> </section> <section id="CD014685-sec-0047"> <h4 class="title">Excluded studies</h4> <p>We excluded 22 screened studies; 18 were not randomised, two were preclinical studies where the liver was not transplanted, and two presented no primary data (review/editorial); further details on these studies are available in the <a href="./references#CD014685-sec-0103" title="">Characteristics of excluded studies</a> table. None of these studies provided any useful data regarding reports of harm. </p> </section> <section id="CD014685-sec-0048"> <h4 class="title">Studies awaiting classification</h4> <p>One study (two records) is awaiting classification (<a href="./references#CD014685-sec-0104" title="">Characteristics of studies awaiting classification</a> table). </p> </section> <section id="CD014685-sec-0049"> <h4 class="title">Ongoing studies</h4> <p>Eleven studies are ongoing (<a href="./references#CD014685-sec-0105" title="">Characteristics of ongoing studies</a> table). </p> </section> </section> <section id="CD014685-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed bias using the RoB 2 tool at the outcome level (<a href="./references#CD014685-bbs2-0072" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021b</a>). These judgements, along with justifications, are given alongside relevant analyses and in the <a href="./references#CD014685-sec-0106" title="">Risk of bias (tables)</a>. The RoB 2 Excel spreadsheet which was used to generate these judgements is available upon request. </p> <section id="CD014685-sec-0051"> <h4 class="title">Bias arising from the randomisation process</h4> <p>All trials reported suitable methods for randomisation. Most trials used centralised electronic randomisation (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> used sealed envelopes and <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> used either centralised electronic randomisation or Microsoft Excel, depending on the centre. Six trials were at low risk of bias in this domain, across all assessed outcomes (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). </p> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> allocated recipients to interventions and concealed the allocation until recipients were enroled into the trial. However, allocation was revealed to the retrieving/implanting team prior to the visual assessment of the liver in the donor. The implanting surgeon could decline the liver for transplantation at that stage, with knowledge of the assigned group, before the intervention (NMP or SCS) had begun. When being assessed in the donor (before retrieval of the liver), the implanting surgeon was significantly more likely to accept a DCD liver for a recipient who was randomised to machine perfusion. As this decision happened prior to retrieval and initiation of preservation, this highlights a lack of equipoise amongst implanting surgeons. Therefore, the baseline risk profile of donors was different, prior to initiation of NMP or SCS, with significantly more DCD liver transplants in the NMP group. </p> </section> <section id="CD014685-sec-0052"> <h4 class="title">Bias due to deviations from intended interventions</h4> <p>In machine perfusion trials, the intervention is initiated, performed, and completed before the implant of the liver takes place. Therefore, issues of 'non‐adherence', and participants in the control group later seeking out the intervention, cannot occur. In six trials all/nearly all participants received the intervention that they were assigned to and an appropriate ITT analysis was performed, making them low risk of bias for this domain across all assessed outcomes (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). </p> <p>As discussed above, in <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>, many more DCD livers which were allocated to NMP ended up receiving this intervention, whereas many DCD livers allocated to SCS never received this intervention. In addition, <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> used per‐protocol analyses for their primary analyses. For some outcomes, an ITT analysis is also given (judgement of some concerns in this domain), but for other outcomes, only per‐protocol was available (judgement of high risk of bias). </p> </section> <section id="CD014685-sec-0053"> <h4 class="title">Bias due to missing outcome data</h4> <p>In five trials there were few missing data, and this was clearly reported; these trials were considered low risk in this domain (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). </p> <p>In <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>, the unit of randomisation was the liver, but recipient outcomes were clearly only available for transplanted grafts. A significantly higher proportion of participants were transplanted in the NMP group — as fewer grafts were discarded in the NMP group, it may be that the baseline risk profile of transplanted grafts was higher than for SCS livers. However, it was unclear whether the extra grafts which were transplanted in the NMP group were genuinely lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore caused bias in favour of SCS for recipient outcomes. For this reason, <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> was at some concerns in this domain. </p> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> was also biased in this domain for similar reasons. In addition, data on loss to follow‐up was not clear for some outcomes. For one‐year graft survival (98% for NMP versus 99% for SCS) the numbers at risk at one year (eFigure 2 in the supplemental content of the primary reference for the study) were 104 in the NMP group and 105 in the SCS group; it is not clear how participants were lost to follow‐up, so this outcome was at high risk in this domain. </p> </section> <section id="CD014685-sec-0054"> <h4 class="title">Bias in measurement of the outcome</h4> <p>Four trials were at low risk across all outcomes, except adverse events (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). Adverse events in these trials were assessed by teams which were not blinded (due to the nature of the intervention) — knowledge of assignment to treatment group may have altered the decision to report an event as an adverse event. <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> was low risk of bias across all assessed outcomes, including adverse events as two independent blinded clinicians assessed adverse events. </p> <p><a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> was at low risk across all outcomes included in the review. Some outcomes were added post‐hoc, and not predefined in the protocol. Due to the risk of bias that this introduces, these post‐hoc outcomes were discussed narratively and not included in any meta‐analyses. </p> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> was at low risk of bias in this domain for the outcome of participant survival. For graft survival, <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> was graded 'some concerns' as the definition was not prespecified, it is not clear whether this was death‐censored. <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> was at high risk of bias for the outcomes serious adverse events and ischaemic biliary complications; clinical teams clearly believed that SCS was inferior to NMP (higher chance of rejecting livers prior to retrieval if the recipient was randomised to SCS) — these same teams may have been more likely to order investigations/biopsies in participants receiving SCS organs. No information was given on the number of investigations performed in each group, and no protocol biopsies/imaging were mentioned. This bias persisted even though the radiologists were blinded. </p> </section> <section id="CD014685-sec-0055"> <h4 class="title">Bias in selection of the reported result</h4> <p>Six trials were at low risk of bias in this domain across every assessed outcome (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). </p> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> was at high risk of bias in this domain for the outcome ischaemic biliary complications. Trial authors combined both non‐anastomotic strictures and bile leaks, and labelled them as 'ischaemic biliary complications'. Anastomotic strictures are not included in this definition — including bile leaks in the definition of ischaemic biliary complications is not standard. This definition was not prespecified in the protocol, which stated that they would investigate biliary strictures as an endpoint. Combining two distinct outcomes (non‐anastomotic strictures and bile leaks), post‐hoc, was judged to put them at high risk of bias. </p> </section> <section id="CD014685-sec-0056"> <h4 class="title">Other risk of bias</h4> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> received for‐profit funding from Transmedics who led the trial design and were responsible for data collection and generating the trial report; this raised concern about potential bias, especially for certain outcomes where the report used non‐standard definitions. <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> received not‐for‐profit funding to run the trial, in addition to Bridge to Life providing UW preservation solution; this element is for‐profit, but Bridge to Life had no other role in the trial. All other trials received not‐for‐profit funding (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>). </p> </section> </section> <section id="CD014685-sec-0057"> <h3 class="title" id="CD014685-sec-0057">Effects of interventions</h3> <p>See: <a href="./full#CD014685-tbl-0001"><b>Summary of findings 1</b> Hypothermic oxygenated perfusion (HOPE) compared with static cold storage (SCS) for preservation of livers prior to transplantation</a>; <a href="./full#CD014685-tbl-0002"><b>Summary of findings 2</b> Normothermic machine perfusion (NMP) compared with static cold storage (SCS) for preservation of livers prior to transplantation</a> </p> <section id="CD014685-sec-0058"> <h4 class="title">Overall participant survival</h4> <p><a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> provided an HR and CIs which could be used directly in meta‐analysis. <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>, <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>, <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>, and <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> did not provide HRs but did perform time‐to‐event analyses which allowed estimation of HRs (<a href="./references#CD014685-bbs2-0120" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials2007;8(1):16.">Tierney 2007</a>). </p> <p>It is uncertain whether HOPE reduces overall participant survival compared with SCS (HR 0.91, 95% CI 0.42 to 1.98; P = 0.81, I<sup>2</sup> = 0%; 4 trials, 482 recipients; <a href="./references#CD014685-fig-0002" title="">Analysis 1.1</a>; low‐certainty evidence due to imprecision because of low number of events). There was no evidence that this effect differed in DCD versus DBD grafts (P = 0.36). Sensitivity analyses using a fixed‐effect model and removing trials with for‐profit funding yielded similar results. It remains uncertain whether NMP reduces participant survival compared with SCS (HR 1.08, 95% CI 0.31 to 3.80; P = 0.90; 1 trial, 222 recipients; <a href="./references#CD014685-fig-0009" title="">Analysis 2.1</a>; very low‐certainty evidence due to imprecision and risk of bias). </p> <p>An indirect comparison of HOPE versus NMP using the results of <a href="./references#CD014685-fig-0002" title="">Analysis 1.1</a> and <a href="./references#CD014685-fig-0009" title="">Analysis 2.1</a> was performed with the techniques of <a href="./references#CD014685-bbs2-0048" title="BucherHC , GuyattGH , GriffithLE , WalterSD . The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology1997;50(6):683-91.">Bucher 1997</a>; it is uncertain whether HOPE impacts on overall participant survival when compared with NMP (indirect HR 0.84, 95% CI 0.19 to 3.68; P = 0.83; very low‐certainty evidence due to the NMP versus SCS comparison). </p> <p><a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> investigated participant survival at six months and found that 10/10 participants in the NMP group were alive and 9/10 in the SCS group were alive (overall risk of bias for this outcome was low); as there were no events in the NMP group an HR could not be calculated. <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> did not provide an ITT analysis for overall participant survival. Their per‐protocol analysis revealed overall participant survival of 94% in the NMP group versus 93.7% in the SCS group (no P value reported); overall risk of bias for this outcome was high risk. </p> </section> <section id="CD014685-sec-0059"> <h4 class="title">Quality of life</h4> <p>No trials reported on any quality of life measures.</p> </section> <section id="CD014685-sec-0060"> <h4 class="title">Serious adverse events</h4> <p><a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a> and <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a> both reported the number of recipients experiencing serious adverse events based on Clavien‐Dindo classification within three months. Meta‐analysis of these studies confirmed a reduction in serious adverse events with HOPE versus SCS in extended criteria DBD livers (OR 0.45, 95% CI 0.22 to 0.91; P = 0.03, I<sup>2</sup> = 0%; 2 trials, 156 recipients; <a href="./references#CD014685-fig-0003" title="">Analysis 1.2</a>; moderate‐certainty evidence). Sensitivity analysis with a fixed‐effect model did not alter these results. </p> <p><a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> examined serious adverse events (Clavien‐Dindo 3a or greater) within the first year post‐transplant and found 44/85 recipients in the HOPE group versus 46/85 in the SCS group experienced a serious adverse event. <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> performed a post‐hoc analysis of serious adverse events (Clavien‐Dindo 3b or greater) which blinded assessors defined as liver‐graft‐related; they reported a reduction in such events (7/85 in the HOPE group versus 17/85 in the SCS group; P = 0.027). </p> <p><a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> and <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> provided data on the total number of serious adverse events, but not the number of people experiencing serious adverse events. <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> reported 101 serious adverse events across 78 recipients of HOPE livers, and 132 serious adverse events across 78 recipients of SCS livers (overall low risk of bias). <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> reported 21 serious adverse events across 121 recipients of NMP livers and 36 serious adverse events across 101 recipients of SCS livers (overall some concerns of bias). <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> did not provide details on overall serious adverse events but provided information on liver‐specific serious adverse events (predefined as primary non‐function, ischaemic biliary complications, hepatic vascular complications, or liver graft infection within 30 days); the trial authors reported 7/153 in the NMP group versus 11/146 in the SCS group experienced liver‐specific serious adverse events (overall some concerns of bias). <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> provided no information on the number of serious adverse events in either group. Overall, there is good evidence that NMP is safe and does not increase the rate of serious adverse events. </p> </section> <section id="CD014685-sec-0061"> <h4 class="title">Graft survival</h4> <p><a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> provided an HR and CIs which could be used directly in meta‐analysis. <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>, <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>, <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>, <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>, and <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> performed time‐to‐event analyses (Kaplan‐Meier with logrank tests) which allowed estimation of HRs (<a href="./references#CD014685-bbs2-0120" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials2007;8(1):16.">Tierney 2007</a>). </p> <p>Four trials compared HOPE with SCS (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). There was an improvement in graft survival with HOPE compared to SCS alone (HR 0.45, 95% CI 0.23 to 0.87; P = 0.02, I² = 0%; 4 trials, 482 recipients; <a href="./references#CD014685-fig-0004" title="">Analysis 1.3</a>; high‐certainty evidence). On subgroup analysis, HOPE improved graft survival versus SCS in the "extended criteria" DBD group (HR 0.30, 95% CI 0.11 to 0.82; P = 0.02, I² = 0%; 2 trials, 156 recipients; <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-fig-0004" title="">Analysis 1.3</a>; high‐certainty evidence). Sensitivity analysis using a fixed‐effect model, and removing trials which received for‐profit funding, did not alter these results. There was no evidence of a differing treatment effect in livers from DCD or DBD donors (P = 0.51, I² = 0%; <a href="./references#CD014685-fig-0004" title="">Analysis 1.3</a>). </p> <p>In contrast, NMP was not associated with a reduction in graft survival (HR 1.20, 95% CI 0.44 to 3.29; P = 0.72, I² = 0%; 2 trials, 522 recipients; <a href="./references#CD014685-fig-0010" title="">Analysis 2.2</a>; low‐certainty evidence due to imprecision and risk of bias). Sensitivity analyses using a fixed‐effect model, and removing <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> (due to risk of bias and for‐profit funding), did not change these conclusions. </p> <p>An indirect comparison of HOPE versus NMP using the results of <a href="./references#CD014685-fig-0004" title="">Analysis 1.3</a> and <a href="./references#CD014685-fig-0010" title="">Analysis 2.2</a> was performed with the techniques of <a href="./references#CD014685-bbs2-0048" title="BucherHC , GuyattGH , GriffithLE , WalterSD . The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology1997;50(6):683-91.">Bucher 1997</a>; HOPE was associated with improved graft survival compared to NMP (indirect HR 0.38, 95% CI 0.11 to 1.23; P = 0.106; low‐certainty evidence due to the NMP versus SCS comparison). </p> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> described graft survival at 12 months; however, they only provided a per‐protocol analysis and gave no specific details on loss to follow‐up (although number at risk in their eFigure 2 in the supplemental content of the primary reference for the study suggested significant loss to follow‐up); sensitivity analysis removing this trial from <a href="./references#CD014685-fig-0010" title="">Analysis 2.2</a> did not change the conclusions. <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> investigated graft survival at six months and found one graft loss out of the 10 recipients in the NMP group and no graft losses in the 10 recipients in the SCS group (overall risk of bias for this outcome was low risk); as there were no events in the SCS group an HR could not be calculated. </p> </section> <section id="CD014685-sec-0062"> <h4 class="title">Ischaemic biliary complications</h4> <p><a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> assessed ischaemic biliary complications in livers from DCDs; crucially they specified clinically significant ischaemic cholangiopathy (with jaundice, recurrent cholangitis, or cholestatic liver "function" test derangement) and two blinded radiologists reviewed imaging with central blinded review of all clinical cases. This confirmed a reduction in ischaemic cholangiopathy with HOPE versus SCS in DCD livers at six months (OR 0.31, 95% CI 0.11 to 0.92; P = 0.03). <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> reported non‐anastomotic strictures at 12 months in DBD donors. Overall, HOPE decreased ischaemic biliary complications compared with SCS (OR 0.32, 95% CI 0.12 to 0.83; P = 0.02; 2 trials, 326 recipients; <a href="./references#CD014685-fig-0005" title="">Analysis 1.4</a>; high‐certainty evidence) </p> <p><a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> assessed non‐anastomotic strictures on protocol magnetic resonance cholangiopancreatography at six months (defined as stricture greater than 70% luminal diameter); it is unclear how many of these were clinically significant. They found minimal differences between the two groups (OR 0.78, 95% CI 0.27 to 2.27; P = 0.65; 1 trial, 155 recipients; <a href="./references#CD014685-fig-0011" title="">Analysis 2.3</a>; very low‐certainty evidence due to imprecision and risk of bias). This trial included DBD and DCD grafts and there was no difference when these subgroups were examined separately. At one year, they described two 'clinically relevant' recipients with ischaemic cholangiopathy (no specific definition given); one in the NMP group and one in the SCS group. </p> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> assessed ischaemic biliary complications with NMP versus SCS. Their definition of ischaemic biliary complications in the final manuscript was non‐anastomotic strictures or bile leaks (but not anastomotic strictures). Including anastomotic bile leaks in the definition of ischaemic biliary complications is not standard, and was not prespecified in their protocol (which only included non‐anastomotic strictures). There was no breakdown of the number of recipients experiencing non‐anastomotic strictures, and therefore true differences in the rate of ischaemic biliary complications could not be assessed. They also provided no definition for non‐anastomotic strictures or bile leaks, or whether these were clinically significant. Results discussed below regarding transplant utilisation also highlighted that surgeons performing transplantation in the trial believed that NMP was superior to SCS; teams (which were unblinded) may therefore have been more likely to request subsequent imaging for recipients in the SCS group — no information was given on how many recipients in each group received imaging. <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> reported a reduction in their composite outcome of non‐anastomotic strictures plus bile leaks of 4/153 in the NMP group and 14/146 in the SCS group (overall high risk of bias). </p> <p><a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> reported no ischaemic biliary complications in either group over six months of follow‐up (10 per group). <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a> and <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>, which both investigated HOPE versus SCS in grafts from DBD donors, did not include ischaemic biliary complications as an outcome. </p> </section> <section id="CD014685-sec-0063"> <h4 class="title">Primary non‐function</h4> <p>All seven trials reported on primary non‐function. It is uncertain whether HOPE reduces primary non‐function compared with SCS (OR 0.32, 95% CI 0.07 to 1.43; I<sup>2</sup> = 0%, P = 0.13; 4 trials, 482 recipients; <a href="./references#CD014685-fig-0006" title="">Analysis 1.5</a>; low‐certainty evidence due to imprecision). Sensitivity analyses using a fixed‐effect model, and removing trials with for‐profit funding yielded similar results. </p> <p><a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> and <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> reported no recipients with primary non‐function in either group. <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> reported 1 episode/121 recipients with primary non‐function in the NMP group versus 0 episodes/101 recipients with primary non‐function in the SCS group. </p> </section> <section id="CD014685-sec-0064"> <h4 class="title">Early allograft dysfunction</h4> <p>All trials assessed early allograft dysfunction at one week using the <a href="./references#CD014685-bbs2-0095" title="OlthoffKM , KulikL , SamsteinB , KaminskiM , AbecassisM , EmondJ , et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transplantation2010;16(8):943-9.">Olthoff 2010</a> definition. Part of this definition relates to peak transaminases (at any time within the first week), which are potentially flawed in machine perfusion studies given the preservation washout effects; trials did not provide sufficient data on which recipients were diagnosed with early allograft dysfunction based solely on peak transaminase levels to allow us to adjust for this. As a result, it is unclear whether reducing early allograft dysfunction in this setting represents a real difference in graft injury or confers no benefit to the transplant recipient. </p> <p>HOPE reduced early allograft dysfunction compared with SCS (OR 0.35, 95% CI 0.23 to 0.53; P &lt; 0.001; 4 trials, 482 recipients; <a href="./references#CD014685-fig-0007" title="">Analysis 1.6</a>; high‐certainty evidence). This effect was similar in DCD and extended criteria DBD subgroups (<a href="./references#CD014685-fig-0007" title="">Analysis 1.6</a>). Sensitivity analyses using a fixed‐effect model, and removing studies with for‐profit funding yielded similar results. </p> <p>NMP probably reduces early allograft dysfunction compared with SCS (OR 0.40, 95% CI 0.22 to 0.74; P = 0.23, I² = 33%; 3 trials, 540 recipients; <a href="./references#CD014685-fig-0012" title="">Analysis 2.4</a>; moderate‐certainty evidence due to risk of bias). Sensitivity analyses using a fixed‐effect model, and removing <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> (for‐profit funding and high risk of bias), did not change these conclusions. </p> <p>An indirect comparison of HOPE versus NMP using the results of <a href="./references#CD014685-fig-0007" title="">Analysis 1.6</a> and <a href="./references#CD014685-fig-0012" title="">Analysis 2.4</a> was performed with the techniques of <a href="./references#CD014685-bbs2-0048" title="BucherHC , GuyattGH , GriffithLE , WalterSD . The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology1997;50(6):683-91.">Bucher 1997</a>; there was no evidence of a difference between HOPE and NMP on early allograft dysfunction (indirect OR 0.88, 95% CI 0.42 to 1.83; P = 0.74; low‐certainty evidence due to the NMP versus SCS comparison). </p> </section> <section id="CD014685-sec-0065"> <h4 class="title">Adverse events not considered serious</h4> <p>Two trials reported the number of participants experiencing any adverse event (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>). <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a> suggested no evidence of a difference in proportion of recipients with any adverse event between HOPE and SCS groups (OR 0.18, 95% CI 0.01 to 4.03; P = 0.28; 1 trial, 6 recipients; low‐certainty evidence due to risk of bias and imprecision). This result is imprecise (wide CIs) as almost all participants in each group experienced at least one adverse event. <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a> also reported on adverse events using the Comprehensive Complication Index, a validated metric to summarise adverse events in surgical trials (<a href="./references#CD014685-bbs2-0116" title="SlankamenacK , GrafR , BarkunJ , PuhanMA , ClavienPA . The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Annals of Surgery2013;258(1):1-7.">Slankamenac 2013</a>). They found a reduction in the Comprehensive Complication Index with HOPE compared with SCS at both 90 days (median: 32 in HOPE group versus 52 in SCS group; P = 0.02) and six months (median: 35 in HOPE group versus 56 in SCS group; P = 0.03) (moderate‐certainty evidence). </p> <p><a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> demonstrated that NMP did not reduce the proportion of participants experiencing any adverse event compared with SCS (OR 0.92, 95% CI 0.54 to 1.57; P = 0.76; 1 trial, 222 recipients; moderate‐certainty evidence due to risk of bias). </p> <p>Three trials reported the total number of adverse events between the two groups (<a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> reported 644 adverse events across 78 recipients in the HOPE group versus 694 adverse events across 78 recipients in the SCS group (no statistical analysis; overall some concerns of risk of bias). <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a> reported 143 adverse events across 55 recipients in the HOPE group versus 190 adverse events across 55 recipients in the SCS group (no statistical analysis; overall high risk of bias). <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> reported 616 adverse events across 85 recipients in the HOPE group versus 574 adverse events across 85 recipients in the SCS group. Two trials did not clearly state either the total number of adverse events or the number of participants experiencing any adverse event (<a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>). </p> <p>Overall, there are no significant safety concerns for either HOPE or NMP based on these results. </p> </section> <section id="CD014685-sec-0066"> <h4 class="title">Transplant utilisation</h4> <p>There were no cluster randomised trials that could be used to assess transplant utilisation. <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>, <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>, <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>, <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>, and <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> all performed the randomisation process after the final decision to accept a liver, and therefore all, or nearly all, randomised livers were transplanted. </p> <p>In contrast, for <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> and <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>, the randomisation and allocation process occurred before the final decision to transplant the liver. These trials assessed utilisation by dividing the number of livers transplanted in each group by the number of recipients (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>) or livers allocated to that group (<a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>). </p> <p>In <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> where livers were the unit of randomisation, 121/137 livers undergoing NMP were transplanted and 101/133 livers undergoing SCS were transplanted; a 50% lower rate of organ discard (P = 0.008). It is not clear whether this result represents the ability to prolong preservation time, the use of viability criteria, or a lack of equipoise amongst transplanting surgeons with a preheld belief that NMP was superior to SCS. </p> <p><a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> used recipients as the unit of randomisation. Allocation was revealed to the retrieval team and implanting surgeon before the liver had been visualised. In DBD grafts, <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> reported 124 transplants from 154 livers in the NMP group versus 133 transplants from 168 livers in the SCS group (P = 0.762). In DCD grafts, they reported 28 transplants from 55 livers in the NMP group versus 13 transplants from 51 livers in the SCS group (P = 0.007). However, the only difference was the number of livers declined on visual inspection, whilst still in the donor (i.e. prior to being placed on the NMP device or undergoing SCS). Therefore, this effect can only represent a lack of equipoise rather than an effect specific to the machine — the implanting team clearly believed in the superiority of NMP over SCS, or at least its ability to assess viability. Transplant utilisation was not a prespecified outcome, and the trial was not designed to assess utilisation. </p> <p>It is worth noting that the improved utilisation seen in <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> and <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> was not associated with inferior outcomes in the NMP group. However, it is unknown whether similar outcomes would have been achieved if the discarded livers in the SCS group were transplanted. </p> </section> <section id="CD014685-sec-0067"> <h4 class="title">Transaminase release during the first week post‐transplant</h4> <p>Again, it must be highlighted that whilst machine perfusion interventions appear to reduce peak serum transaminases post‐transplant when compared with SCS this may simply reflect a flush‐out effect during machine perfusion. Even if flush‐out does not represent the entire effect, there are no definitive data to show that reducing post‐transplant transaminase release would lead to improved clinically relevant outcomes. Therefore, we discuss these results only narratively below. </p> <p>Three trials which compared HOPE versus SCS reported on this outcome (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). <a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a> found that HOPE was associated with a significant reduction in peak alanine transaminase in the first week versus SCS (median 418 in the HOPE group versus 796 in the SCS group; P = 0.030). <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a> reported mean peak one‐week alanine transaminase of 1026 in the HOPE group versus 1259 in the SCS group (they performed no statistical analysis on this comparison). <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a> analysed area under curves for transaminase release in the first week and found no important differences between HOPE and SCS groups. </p> <p>Two NMP versus SCS trials reported on peak serum transaminases post‐transplant (<a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>). <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> found a reduction in peak aspartate transaminase in the first week post‐transplant in the NMP group compared with the SCS group (geometric mean: 485 in the NMP group versus 974 in the SCS group; P &lt; 0.001). The pilot trial of <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> found no important differences in peak transaminases in the first week, but was not powered for this. <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> and <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a> did not report on transaminase release post‐transplant, except indirectly via early allograft dysfunction as reported above. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD014685-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD014685-sec-0068"></div> <section id="CD014685-sec-0069"> <h3 class="title" id="CD014685-sec-0069">Summary of main results</h3> <p>We identified four randomised clinical trials which compared HOPE with SCS (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>), and three randomised trials comparing NMP with SCS (<a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a>; <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). </p> <p>Trials comparing HOPE with SCS were at low risk of bias across almost all outcomes and showed convincing improvements in outcomes which are relevant to clinicians, patients, and healthcare providers. When compared with conventional SCS, HOPE improved graft survival (HR 0.45, 95% CI 0.23 to 0.87; P = 0.02, I² = 0%; 4 trials, 482 recipients; <a href="./references#CD014685-fig-0004" title="">Analysis 1.3</a>; high‐certainty evidence), reduced serious adverse events in extended criteria DBD liver transplant (OR 0.45, 95% CI 0.22 to 0.91; P = 0.03, I<sup>2</sup> = 0%; 2 trials, 156 recipients; <a href="./references#CD014685-fig-0003" title="">Analysis 1.2</a>; moderate‐certainty evidence), and reduced clinically significant ischaemic cholangiopathy in recipients of DCD livers (OR 0.31, 95% CI 0.11 to 0.92; P = 0.03; 1 trial, 156 recipients; <a href="./references#CD014685-fig-0005" title="">Analysis 1.4</a>; high‐certainty evidence). </p> <p>In contrast, trials comparing NMP with SCS found no improvement in any of these three important outcomes. There is evidence that NMP is able to reduce the discard rate of livers (<a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> showed a 50% lower rate of organ discard). However, no study to date has been primarily designed to assess this. Whether this reduced discard relates to the capacity for increased preservation time, the ability to assess viability, or a preheld belief by surgeons that NMP is superior is unclear. It is also uncertain whether this effect is specific to NMP, or whether it could be achieved with other machine perfusion technologies. </p> <p>It is uncertain whether overall participant survival is impacted by either HOPE (HR 0.91, 95% CI 0.42 to 1.98; P = 0.81, I<sup>2</sup> = 0%; 4 trials, 482 recipients; <a href="./references#CD014685-fig-0002" title="">Analysis 1.1</a>; low‐certainty evidence due to imprecision because of low number of events) or NMP (HR 1.08, 95% CI 0.31 to 3.80; P = 0.90; 1 trial, 222 recipients; <a href="./references#CD014685-fig-0009" title="">Analysis 2.1</a>; very low‐certainty evidence due to imprecision and risk of bias) when compared with SCS. It is worth noting that power to detect differences in overall participant survival are low, due to the low number of deaths. We consider that the improvements in graft survival discussed above would likely lead to improvements in overall participant survival in trials with a larger sample size. No trials reported on quality of life. </p> <p>We identified no trials randomising recipients to normothermic regional perfusion. In the setting of DCD transplantation, several previous cohort studies have suggested improved liver graft survival and a reduction in ischaemic cholangiopathy when compared to standard organ procurement and SCS (<a href="./references#CD014685-bbs2-0056" title="De BeuleJ , VandendriesscheK , PengelLH , BelliniMI , DarkJH , HessheimerAJ , et al. A systematic review and meta-analyses of regional perfusion in donation after circulatory death solid organ transplantation. Transplant International2021;34(11):2046-60.">De Beule 2021</a>; <a href="./references#CD014685-bbs2-0097" title="OniscuGC , MehewJ , ButlerAJ , SutherlandA , GauravR , HoggR , et al. Improved organ utilization and better transplant outcomes with in situ normothermic regional perfusion in controlled donation after circulatory death. Transplantation2023;107(2):438-48. [DOI: 10.1097/TP.0000000000004280]">Oniscu 2023</a>). This has seen increasing use of normothermic regional perfusion worldwide, with some arguing that the positive results from cohort studies would make a randomised trial unethical (<a href="./references#CD014685-bbs2-0056" title="De BeuleJ , VandendriesscheK , PengelLH , BelliniMI , DarkJH , HessheimerAJ , et al. A systematic review and meta-analyses of regional perfusion in donation after circulatory death solid organ transplantation. Transplant International2021;34(11):2046-60.">De Beule 2021</a>; <a href="./references#CD014685-bbs2-0070" title="HessheimerAJ , CollE , TorresF , RuizP , GastacaM , RivasJI , et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. Journal of Hepatology2019;70(4):658-65.">Hessheimer 2019</a>; <a href="./references#CD014685-bbs2-0097" title="OniscuGC , MehewJ , ButlerAJ , SutherlandA , GauravR , HoggR , et al. Improved organ utilization and better transplant outcomes with in situ normothermic regional perfusion in controlled donation after circulatory death. Transplantation2023;107(2):438-48. [DOI: 10.1097/TP.0000000000004280]">Oniscu 2023</a>; <a href="./references#CD014685-bbs2-0108" title="SavierE , LimC , RayarM , OrlandoF , BoudjemaK , MohkamK , et al. Favorable outcomes of liver transplantation from controlled circulatory death donors using normothermic regional perfusion compared to brain death donors. Transplantation2020;104(9):1943-51.">Savier 2020</a>). Due to a lack of randomised clinical trials, how HOPE and NMP compare with normothermic regional perfusion is uncertain. It is also unclear whether the benefits seen with HOPE following standard DCD retrieval (shown in this review) would extend to HOPE following normothermic regional perfusion, or whether one of these techniques is sufficient in isolation. </p> <p>Another interesting development has been the combination of ex situ techniques; HOPE has been used to resuscitate/optimise livers, prior to a period of NMP for viability assessment (<a href="./references#CD014685-bbs2-0124" title="vanLeeuwenOB , deVriesY , deMeijerVE , PorteRJ . Hypothermic machine perfusion before viability testing of previously discarded human livers. Nature Communications2021;12(1):1008.">van Leeuwen 2021</a>). In this setting, the liver is often slowly rewarmed from hypothermia to normothermia (termed 'controlled oxygenated rewarming'), a technique which has been shown to salvage livers otherwise deemed untransplantable, with excellent transplant outcomes in a single armed prospective clinical trial (<a href="./references#CD014685-bbs2-0123" title="vanLeeuwenOB , deVriesY , FujiyoshiM , NijstenMW , UbbinkR , PelgrimGJ , et al. Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial. Annals of Surgery2019;270(5):906-14.">van Leeuwen 2019</a>). These techniques are yet to be studied in randomised clinical trials, although selecting a control arm in such a trial would be challenging as the technique is primarily used for livers which have otherwise been declined for transplant. </p> <p>We have attempted to focus on outcomes that are the most relevant and important for patients, clinicians, and healthcare organisations. We have not included outcomes such as post‐reperfusion syndrome (a transient phenomenon) or length of hospital stay, following advice from the Cochrane Hepato‐Biliary editorial team. In addition, we have avoided making conclusions based solely on recipient peak transaminases. There is a lack of high‐quality evidence that lower transaminases are a good surrogate for clinically relevant outcomes, and they may simply represent a flush‐out effect during machine perfusion. Although this flush‐out effect is likely to be greater in NMP, where the organ is metabolically active, some transaminases are likely to be flushed out during hypothermic perfusion. </p> <p>We have not considered cost‐effectiveness, although hypothermic techniques are generally less expensive due to their inherent simplicity, both of the circuit and perfusate constituents/infusions (<a href="./references#CD014685-bbs2-0137" title="ZimmermannJ , CarterAW . Cost–utility analysis of normothermic and hypothermic ex-situ machine perfusion in liver transplantation. British Journal of Surgery2022;109(2):e31-2.">Zimmermann 2022</a>). In addition, hypothermic techniques do not generally require blood products, which removes pressure from blood donation services, and avoids logistical issues. </p> <p>The searches were updated by the Cochrane Hepato‐Biliary Editorial team after the peer review process. This identified a pilot study of SCS versus controlled oxygenated rewarming (<a href="./references#CD014685-bbs2-0030" title="ISRCTN94691167. Can warming and supplying oxygen to a donor liver before transplantation improve the success of liver transplants?isrctn.com/ISRCTN94691167 (first received 5 November 2018). MinorT , vonHornC , ZlatevH , SanerF , GraweM , LüerB , et al. Controlled oxygenated rewarming as novel end-ischemic therapy for cold stored liver grafts. A randomized controlled trial. Clinical Translational Science2022;15(12):2918–27. ">Minor 2022</a>). As this was a pilot study and did not include a comparison which would contribute to any of the meta‐analyses, this study has been listed as a 'study awaiting classification' following advice from the Cochrane Hepato‐Biliary Editorial team. This will be assessed/included in the update of the review. </p> </section> <section id="CD014685-sec-0070"> <h3 class="title" id="CD014685-sec-0070">Overall completeness and applicability of evidence</h3> <p>We employed robust search strategies, which included screening of reference lists and searching of clinical trial registries, to ensure we identified all relevant trials. </p> <p>Trials of HOPE versus SCS included both DBD and DCD grafts, which are currently deemed transplantable using SCS. NMP versus SCS trials contained standard and extended criteria DBD livers, as well as DCD grafts. However, the number of transplanted DCD grafts in the NMP trials was low, limiting the applicability of these trials to DCD liver transplant. Whether HOPE or NMP can salvage DCD livers which are considered too high‐risk to be transplanted following SCS remains unknown. </p> <p>Due to the relatively limited number of present trials it is difficult to perform meaningful subgroup analyses. For example, the optimal method of performing HOPE is still not known, although it seems that both dual (hepatic artery and portal vein) and portal vein only HOPE are effective. It is also unclear what the best method of preservation is for other marginal graft types such as steatotic grafts, but trials are underway to assess this (<a href="./references#CD014685-bbs2-0036" title="NCT03930459. Efficacy of ex-situ normothermic perfusion versus cold storage in the transplant with steatotic liver graft. clinicaltrials.gov/show/NCT03930459 (first received 29 April 2019). ">NCT03930459</a>). </p> <p>With regard to DCD grafts, none of these trials used normothermic regional perfusion which is becoming standard, or even mandated, in many countries (<a href="./references#CD014685-bbs2-0070" title="HessheimerAJ , CollE , TorresF , RuizP , GastacaM , RivasJI , et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. Journal of Hepatology2019;70(4):658-65.">Hessheimer 2019</a>; <a href="./references#CD014685-bbs2-0097" title="OniscuGC , MehewJ , ButlerAJ , SutherlandA , GauravR , HoggR , et al. Improved organ utilization and better transplant outcomes with in situ normothermic regional perfusion in controlled donation after circulatory death. Transplantation2023;107(2):438-48. [DOI: 10.1097/TP.0000000000004280]">Oniscu 2023</a>; <a href="./references#CD014685-bbs2-0108" title="SavierE , LimC , RayarM , OrlandoF , BoudjemaK , MohkamK , et al. Favorable outcomes of liver transplantation from controlled circulatory death donors using normothermic regional perfusion compared to brain death donors. Transplantation2020;104(9):1943-51.">Savier 2020</a>). The effect of these interventions, when delivered following normothermic regional perfusion, is not known. This is clearly not a concern when considering the use of machine perfusion in DBD grafts. </p> </section> <section id="CD014685-sec-0071"> <h3 class="title" id="CD014685-sec-0071">Quality of the evidence</h3> <p>The four trials comparing HOPE with SCS were at low risk of bias using RoB 2 across all domains for the majority of assessed outcomes (<a href="./references#CD014685-bbs2-0001" title="CziganyZ , PratschkeJ , FronekJ , GubaM , SchoningW , RaptisDA , et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Annals of Surgery2021;274(5):705-12. CziganyZ , SchoningW , UlmerTF , BednarschJ , AmygdalosI , CramerT , et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open2017;7(10):e017558. NCT03124641. HOPE for human extended criteria and donation after brain death donor (ECD-DBD) liver allografts. clinicaltrials.gov/show/NCT03124641 (First posted 24 April 2017). ">Czigany 2021</a>; <a href="./references#CD014685-bbs2-0005" title="NCT03837197. Clinical trial of new hypothermic oxygenated perfusion system versus static cold storage. clinicaltrials.gov/show/NCT03837197 (first received 12 February 2019). RavaioliM , GerminarioG , DajtiG , SessaM , VasuriF , SiniscalchiA , et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation – a randomized clinical trial. American Journal of Transplantation2022;22(10):2401-8. RavaioliM , GerminarioG , MaroniL , OdaldiF , FallaniG , ProsperiE , et al. Randomized trial on hypothermic oxygenated perfusion vs static cold storage in liver transplantation from extended criteria donors: interim analysis. Transplant International2021;34(Suppl 1):204. RavaioliM , MaroniL , AngelettiA , FallaniG , De PaceV , GerminarioG , et al. Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: protocol for a single-center randomized controlled trial. JMIR Research Protocols2020;9(3):e13922. ">Ravaioli 2022</a>; <a href="./references#CD014685-bbs2-0006" title="NCT01317342. Hypothermic oxygenated perfusion (HOPE) of human liver grafts. clinicaltrials.gov/show/NCT01317342 (first received 17 March 2011). SchlegelA , MuellerM , MullerX , EdenJ , PanconesiR , vonFeltenS , et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. Journal of Hepatology2023;78(4):783-93. ">Schlegel 2023</a>; <a href="./references#CD014685-bbs2-0007" title="FriendP , PollokJM . Hypothermic machine perfusion in liver transplantation – a randomised trial and beyond. Transplant International2022;35:10257. NCT02584283. Dual hypothermic oxygenated perfusion of DCD liver grafts in preventing biliary complications after transplantation. clinicaltrials.gov/show/NCT02584283 (first received 22 October 2015). vanRijnR , De MeijerVE , PorteRJ . Hypothermic machine perfusion in liver transplantation. New England Journal of Medicine2021;385(8):766-8. vanRijnR , SchurinkI , CerisueloMC , De HaasRJ , HeatonN , vanHoekB , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. Transplant International2021;34(Suppl 1):53. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. A randomized controlled trial of dual hypothermic oxygenated machine perfusion in donation after circulatory death liver transplantation. HPB2021;23:S673. vanRijnR , SchurinkIJ , deVriesY , vanden BergAP , Cortes CerisueloM , Darwish MuradS , et al. Hypothermic machine perfusion in liver transplantation – a randomized trial. New England Journal of Medicine2021;384(15):1391-401. vanRijnR , vanden BergAP , ErdmannJI , HeatonN , vanHoekB , deJongeJ , et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterology2019;19(1):40. ">van Rijn 2021</a>). These were well‐designed trials where the majority of randomised livers underwent their allocated intervention and were transplanted, and were at low risk of bias from for‐profit funding. </p> <p>Risk of bias in trials comparing NMP with SCS was mixed. In <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> and <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a>, liver grafts allocated to NMP were more likely to be transplanted that those allocated to SCS; therefore, the baseline quality (prior to intervention) of grafts transplanted following NMP in these trials may be lower than those transplanted following SCS, which may underestimate any benefits of NMP when examining recipient outcomes. This may contribute to the lack of benefits seen with NMP in clinically relevant recipient outcomes. <a href="./references#CD014685-bbs2-0004" title="CeresaC , NasrallaD , WatsonC , ButlerA , CrickK , ImberC , et al. The effect of normothermic machine perfusion after cold storage in liver transplantation: a multicentre prospective clinical trial. Transplantation2018;102(5 Suppl 1):27. DavidN , RutgerP , PeterF . Normothermic machine perfusion vs static cold storage in liver transplantation: outcomes from a randomised controlled trial. Transplant International2017;30(Suppl 2):6. ISRCTN39731134. Work Package 2 (WP2) – normothermic liver perfusion vs cold storage in liver transplants. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN39731134 (first received 27 March 2014). MullerE . A randomized trial of normothermic preservation in liver transplantation. Transplantation2018;102(8):1197-8. NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCDL , et al, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6. NasrallaD , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Transplantation2017;101(5):4. NasrallaD , MergentalH , JassemW , ImberC , ButlerA , PaulA , et al. A randomised controlled trial of normothermic liver perfusion versus cold storage in human liver transplantation. Transplant International2015;28:285. NasrallaD , PloegR , CoussiosC , FriendP . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. American Journal of Transplantation2017;17:404. NasrallaD , PloegR , FriendP . A multicentre randomised controlled trial to compare the efficacy of normothermic machine perfusion with static cold storage in human liver transplantation: early outcomes. Transplantation2016;100(7 Suppl 1):S111. ">Nasralla 2018</a> was otherwise at low risk of bias for all other domains and received not‐for‐profit funding. <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> received for‐profit funding and was deemed high risk for many RoB 2 domains for issues such as the use of non‐standard outcome definitions which differed from their prespecified outcomes. The pilot trial by <a href="./references#CD014685-bbs2-0002" title="GhinolfiD , RrekaE , De SimoneP , InsillaAC , FranziniM , MasiniM , et al. A pilot, double-arm, randomized, prospective, study on normothermic ex-vivo perfusion of elderly liver grafts (&gt;=70 years). Transplant International2017;30(Suppl 2):42. GhinolfiD , RrekaE , De TataV , FranziniM , PezzatiD , FierabracciV , et al. Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors. Liver Transplantation2019;25(3):436-49. GhinolfiD , RrekaE , PaolicchiA , DeTataV , BiancofioreG , MarchettiP , et al. Pilot, open, monocentric, randomized, prospective trial for the evaluation of normothermic machine perfusion for organ preservation in liver transplantation using brain death donors =70 years. Transplantation2018;102(5):118. NCT02940600. Efficacy evaluation of normothermic perfusion machine preservation in liver transplant using very old donors. clinicaltrials.gov/show/NCT02940600 (first received 21 October 2016). ">Ghinolfi 2019</a> was generally at low risk of bias for assessed outcomes. </p> <p>Unfortunately, there were no trials directly comparing NMP and HOPE. For some outcomes it was possible to perform an indirect comparison between NMP and HOPE using techniques described by <a href="./references#CD014685-bbs2-0048" title="BucherHC , GuyattGH , GriffithLE , WalterSD . The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology1997;50(6):683-91.">Bucher 1997</a>. As no trials directly compared these interventions, heterogeneity could not be assessed for the HOPE versus NMP comparison. </p> </section> <section id="CD014685-sec-0072"> <h3 class="title" id="CD014685-sec-0072">Potential biases in the review process</h3> <p>The search for randomised clinical trials was performed using systematic methods following consultation with the Cochrane Hepato‐Biliary information specialist. Two review authors independently screened the identified studies prior to inclusion in the review. Two review authors independently used a standardised data extraction form to collect data from included trials. Subgroup analysis was only performed if prespecified in our protocol, to limit bias from multiple comparisons. Due to the limited number of trials it is difficult to assess publication bias, which may introduce bias into our results. </p> </section> <section id="CD014685-sec-0073"> <h3 class="title" id="CD014685-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>There have been several previous narrative reviews on the topic of machine perfusion in liver transplantation (<a href="./references#CD014685-bbs2-0055" title="CziganyZ , LurjeI , TolbaRH , NeumannUP , TackeF , LurjeG . Machine perfusion for liver transplantation in the era of marginal organs – new kids on the block. Liver International2019;39(2):228-49.">Czigany 2019</a>; <a href="./references#CD014685-bbs2-0113" title="SchlegelA , MullerX , DutkowskiP . Machine perfusion strategies in liver transplantation. Hepatobiliary Surgery and Nutrition2019;8(5):490-501.">Schlegel 2019</a>). In this section we focus on comparisons with previous systematic reviews and meta‐analyses only, specifically those focused on NMP, HOPE, or both. </p> <p>Previous meta‐analyses included both randomised clinical trials and retrospective cohort studies (<a href="./references#CD014685-bbs2-0042" title="BelliniMI , NozdrinM , YiuJ , PapaloisV . Machine perfusion for abdominal organ preservation: a systematic review of kidney and liver human grafts. Journal of Clinical Medicine2019;8(8):1221.">Bellini 2019</a>; <a href="./references#CD014685-bbs2-0043" title="BoteonYL , BoteonAP , AttardJ , WallaceL , BhogalRH , AffordSC . Impact of machine perfusion of the liver on post-transplant biliary complications: a systematic review. World Journal of Transplantation2018;8:220-31.">Boteon 2018</a>; <a href="./references#CD014685-bbs2-0078" title="JakubauskasM , JakubauskieneL , LeberB , StrupasK , StieglerP , SchemmerP . Machine perfusion in liver transplantation: a systematic review and meta-analysis. Visceral Medicine2022;38:243-54.">Jakubauskas 2022</a>; <a href="./references#CD014685-bbs2-0079" title="JiaJ , NieY , LiJ , XieH , ZhouL , YuJ , et al. A systematic review and meta-analysis of machine perfusion vs. static cold storage of liver allografts on liver transplantation outcomes: the future direction of graft preservation. Frontiers in Medicine2020;7:135.">Jia 2020</a>; <a href="./references#CD014685-bbs2-0084" title="LiewB , NasrallaD , IypeS , PollokJM . Liver transplant outcomes after ex vivo machine perfusion: a meta-analysis. British Journal of Surgery2021;108:1409-16.">Liew 2021</a>; <a href="./references#CD014685-bbs2-0136" title="ZhangY , ZhangY , ZhangM , MaZ , WuS . Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a meta-analysis. Medicine2019;98:e16033.">Zhang 2019</a>), whereas we have focussed only on randomised clinical trials due to their superior level of evidence. All of these meta‐analyses found that HOPE reduces ischaemic biliary complications, and none of these meta‐analyses found a significant impact of NMP on ischaemic biliary complications (<a href="./references#CD014685-bbs2-0042" title="BelliniMI , NozdrinM , YiuJ , PapaloisV . Machine perfusion for abdominal organ preservation: a systematic review of kidney and liver human grafts. Journal of Clinical Medicine2019;8(8):1221.">Bellini 2019</a>; <a href="./references#CD014685-bbs2-0043" title="BoteonYL , BoteonAP , AttardJ , WallaceL , BhogalRH , AffordSC . Impact of machine perfusion of the liver on post-transplant biliary complications: a systematic review. World Journal of Transplantation2018;8:220-31.">Boteon 2018</a>; <a href="./references#CD014685-bbs2-0078" title="JakubauskasM , JakubauskieneL , LeberB , StrupasK , StieglerP , SchemmerP . Machine perfusion in liver transplantation: a systematic review and meta-analysis. Visceral Medicine2022;38:243-54.">Jakubauskas 2022</a>; <a href="./references#CD014685-bbs2-0079" title="JiaJ , NieY , LiJ , XieH , ZhouL , YuJ , et al. A systematic review and meta-analysis of machine perfusion vs. static cold storage of liver allografts on liver transplantation outcomes: the future direction of graft preservation. Frontiers in Medicine2020;7:135.">Jia 2020</a>; <a href="./references#CD014685-bbs2-0084" title="LiewB , NasrallaD , IypeS , PollokJM . Liver transplant outcomes after ex vivo machine perfusion: a meta-analysis. British Journal of Surgery2021;108:1409-16.">Liew 2021</a>; <a href="./references#CD014685-bbs2-0136" title="ZhangY , ZhangY , ZhangM , MaZ , WuS . Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a meta-analysis. Medicine2019;98:e16033.">Zhang 2019</a>). Our review is concurrent with these findings, but as it only includes randomised clinical trials the evidence is at lower risk of bias. </p> <p>Previous analyses have been mixed regarding the impact of HOPE on graft survival, with some showing no impact and others showing significant improvements compared with SCS (<a href="./references#CD014685-bbs2-0042" title="BelliniMI , NozdrinM , YiuJ , PapaloisV . Machine perfusion for abdominal organ preservation: a systematic review of kidney and liver human grafts. Journal of Clinical Medicine2019;8(8):1221.">Bellini 2019</a>; <a href="./references#CD014685-bbs2-0079" title="JiaJ , NieY , LiJ , XieH , ZhouL , YuJ , et al. A systematic review and meta-analysis of machine perfusion vs. static cold storage of liver allografts on liver transplantation outcomes: the future direction of graft preservation. Frontiers in Medicine2020;7:135.">Jia 2020</a>; <a href="./references#CD014685-bbs2-0084" title="LiewB , NasrallaD , IypeS , PollokJM . Liver transplant outcomes after ex vivo machine perfusion: a meta-analysis. British Journal of Surgery2021;108:1409-16.">Liew 2021</a>; <a href="./references#CD014685-bbs2-0136" title="ZhangY , ZhangY , ZhangM , MaZ , WuS . Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a meta-analysis. Medicine2019;98:e16033.">Zhang 2019</a>). However, no previous meta‐analysis analysed graft survival as a time‐to‐event variable, instead dichotomising graft survival at one year. No meta‐analysis showed any improvement in graft survival with NMP (<a href="./references#CD014685-bbs2-0042" title="BelliniMI , NozdrinM , YiuJ , PapaloisV . Machine perfusion for abdominal organ preservation: a systematic review of kidney and liver human grafts. Journal of Clinical Medicine2019;8(8):1221.">Bellini 2019</a>; <a href="./references#CD014685-bbs2-0043" title="BoteonYL , BoteonAP , AttardJ , WallaceL , BhogalRH , AffordSC . Impact of machine perfusion of the liver on post-transplant biliary complications: a systematic review. World Journal of Transplantation2018;8:220-31.">Boteon 2018</a>; <a href="./references#CD014685-bbs2-0078" title="JakubauskasM , JakubauskieneL , LeberB , StrupasK , StieglerP , SchemmerP . Machine perfusion in liver transplantation: a systematic review and meta-analysis. Visceral Medicine2022;38:243-54.">Jakubauskas 2022</a>; <a href="./references#CD014685-bbs2-0079" title="JiaJ , NieY , LiJ , XieH , ZhouL , YuJ , et al. A systematic review and meta-analysis of machine perfusion vs. static cold storage of liver allografts on liver transplantation outcomes: the future direction of graft preservation. Frontiers in Medicine2020;7:135.">Jia 2020</a>; <a href="./references#CD014685-bbs2-0084" title="LiewB , NasrallaD , IypeS , PollokJM . Liver transplant outcomes after ex vivo machine perfusion: a meta-analysis. British Journal of Surgery2021;108:1409-16.">Liew 2021</a>; <a href="./references#CD014685-bbs2-0136" title="ZhangY , ZhangY , ZhangM , MaZ , WuS . Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a meta-analysis. Medicine2019;98:e16033.">Zhang 2019</a>). We appropriately analysed graft survival as time‐to‐event data, and use data from randomised trials, to show an improvement in graft survival with HOPE versus SCS; a benefit which is not replicated with NMP. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD014685-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram for the identification of included studies in the meta‐analysis of machine perfusion in liver transplantation (Page 2021a; Page 2021b). Date of last search 10 January 2023." data-id="CD014685-fig-0001" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow diagram for the identification of included studies in the meta‐analysis of machine perfusion in liver transplantation (<a href="./references#CD014685-bbs2-0099" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n71.">Page 2021a</a>; <a href="./references#CD014685-bbs2-0100" title="PageMJ , MoherD , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.)2021;372:n160.">Page 2021b</a>). Date of last search 10 January 2023. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 1: Overall participant survival" data-id="CD014685-fig-0002" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 1: Overall participant survival </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 2: Serious adverse events (90‐day follow‐up)" data-id="CD014685-fig-0003" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 2: Serious adverse events (90‐day follow‐up) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 3: Graft survival" data-id="CD014685-fig-0004" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 3: Graft survival </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 4: Ischaemic biliary complications" data-id="CD014685-fig-0005" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 4: Ischaemic biliary complications </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 5: Primary non‐function" data-id="CD014685-fig-0006" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 5: Primary non‐function </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 6: Early allograft dysfunction" data-id="CD014685-fig-0007" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 6: Early allograft dysfunction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 7: Adverse events considered non‐serious" data-id="CD014685-fig-0008" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS), Outcome 7: Adverse events considered non‐serious </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 1: Overall participant survival" data-id="CD014685-fig-0009" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 1: Overall participant survival </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 2: Graft survival" data-id="CD014685-fig-0010" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 2: Graft survival </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 3: Ischaemic biliary complications (on protocol imaging)" data-id="CD014685-fig-0011" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 3: Ischaemic biliary complications (on protocol imaging) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 4: Early allograft dysfunction" data-id="CD014685-fig-0012" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 4: Early allograft dysfunction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014685-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/urn:x-wiley:14651858:media:CD014685:CD014685-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 5: Adverse events considered non‐serious" data-id="CD014685-fig-0013" src="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_t/tCD014685-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Normothermic machine perfusion (NMP) versus static cold storage (SCS), Outcome 5: Adverse events considered non‐serious </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/media/CDSR/CD014685/image_n/nCD014685-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD014685-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Hypothermic oxygenated perfusion (HOPE) compared with static cold storage (SCS) for preservation of livers prior to transplantation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypothermic oxygenated perfusion (HOPE) compared with static cold storage (SCS) for preservation of livers prior to transplantation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> liver transplant recipients </p> <p><b>Setting:</b> liver transplantation<br/><b>Intervention:</b> hypothermic oxygenated perfusion (HOPE)<br/><b>Comparison:</b> static cold storage (SCS) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with static cold storage (SCS)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with hypothermic oxygenated perfusion (HOPE)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overall participant survival</b><br/>follow‐up: median 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 0.91</b><br/>(0.42 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>482<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It is uncertain whether HOPE improves overall survival due to imprecision because of low numbers of deaths. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>940 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>945 per 1000</b><br/>(885 to 974) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> <p>follow‐up 90 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>449 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>426 per 1000</b><br/>(255 to 617) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.91</b><br/>(0.42 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HOPE reduces serious adverse events compared to SCS; however, the exact magnitude of this effect is unclear due to wide CIs. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Graft survival</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 0.45</b><br/>(0.23 to 0.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>482<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>HOPE improves graft survival compares to SCS alone.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>840 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>925 per 1000</b><br/>(859 to 961) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> total<br/>follow‐up: median 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b><br/>(14 to 88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.32</b><br/>(0.12 to 0.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>326<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In livers donated following circulatory death, HOPE reduces clinically significant ischaemic cholangiopathy compared to SCS alone. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> (donated following brain death (DBD)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/>(1 to 105) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.33</b><br/>(0.03 to 3.19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> (donated following circulatory death (DCD)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>64 per 1000</b><br/>(23 to 168) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.31</b><br/>(0.11 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early allograft dysfunction</b> </p> <p>total<br/>follow‐up: 7 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>398 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b><br/>(132 to 260) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.35</b><br/>(0.23 to 0.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>482<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HOPE reduces early allograft dysfunction compared to SCS alone. As peak post‐transplant transaminases contribute to this outcome, and there is a washout effect during perfusion, this outcome is of questionable clinical relevance. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events considered non‐serious</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>3 studies reported a lower number of total adverse events in the HOPE group compared with the SCS group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>312<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative synthesis could not be performed.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436878198874408136" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436878198874408136</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded two levels due to imprecision. <br/><sup>b</sup> Downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Hypothermic oxygenated perfusion (HOPE) compared with static cold storage (SCS) for preservation of livers prior to transplantation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014685-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Normothermic machine perfusion (NMP) compared with static cold storage (SCS) for preservation of livers prior to transplantation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Normothermic machine perfusion (NMP) compared with static cold storage (SCS) for preservation of livers prior to transplantation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> liver transplant recipients<br/><b>Setting:</b> liver transplantation<br/><b>Intervention:</b> normothermic machine perfusion (NMP)<br/><b>Comparison:</b> static cold storage (SCS) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with static cold storage (SCS)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with normothermic machine perfusion (NMP)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overall participant survival</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 1.08</b><br/>(0.31 to 3.80) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>222<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It is uncertain whether NMP impacts overall participant survival.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>980 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>978 per 1000</b><br/>(926 to 994) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> (SAEs) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD014685-bbs2-0090" title="NasrallaD , CoussiosCC , MergentalH , AkhtarMZ , ButlerAJ , CeresaCD , et al. A randomized trial of normothermic preservation in liver transplantation. Nature2018;557(7703):50-6.">Nasralla 2018</a> reported 21 SAEs across 121 recipients of NMP livers, and 36 SAE across 101 recipients of SCS livers. <a href="./references#CD014685-bbs2-0003" title="MarkmannJ , AbouljoudM , GhobrialM , BhatiC , PelletierS , MaglioccaJ , et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. American Journal of Transplantation2021;21(Suppl 4):455-6. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. American Journal of Transplantation2017;30(Suppl 3):305. MarkmannJ , GhobrialM , MaglioccaJ , DemetrisA , AbouljoudM . Results of the initial phase of the portable organ care system (OCSTM) liver protect pivotal trial. Transplant International2017;30(Suppl 2):43. MarkmannJF , AbouljoudMS , GhobrialRM , BhatiCS , PelletierSJ , LuAD , et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial. JAMA Surgery2022;157(3):189-98. NCT02522871. International randomized trial to evaluate the effectiveness of the portable organ care system (OCS™) liver for preserving and assessing donor livers for transplantation (OCS Liver PROTECT trial). clinicaltrials.gov/ct2/show/NCT02522871 (first received 13 August 2015). ">Markmann 2022</a> reported "liver specific" serious adverse event; 7/153 in the NMP group and 11/146 in the SCS group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>522<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP is not associated with an increase in SAEs compared with SCS; there are no safety concerns. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Graft survival</b><br/>follow‐up: 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>HR 1.20</b><br/>(0.44 to 3.29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>522<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>NMP does not appear to improve graft survival compared to SCS.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>975 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>970 per 1000</b><br/>(920 to 989) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ischaemic biliary complications</b> (on protocol imaging)<br/>follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>86 per 1000</b><br/>(32 to 216) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.78</b><br/>(0.27 to 2.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP does not appear to reduce radiological ischaemic biliary complications, and the effect on clinically significant ischaemic biliary complications is not known. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Early allograft dysfunction</b><br/>follow‐up: 7 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>146 per 1000</b><br/>(86 to 240) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.40</b><br/>(0.22 to 0.74) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>540<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP reduces early allograft dysfunction compared with SCS alone. As peak post‐transplant transaminases contribute to this outcome, and there is a washout effect during perfusion, this outcome is of questionable clinical relevance. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events considered non‐serious</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>574 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>554 per 1000</b><br/>(421 to 679) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.92</b><br/>(0.54 to 1.57) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>222<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NMP does not appear to reduce the proportion of recipients experiencing adverse events compared with SCS. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436879195689026772" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436879195689026772</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level due to risk of bias and two levels due to imprecision (because of low numbers of deaths). <br/><sup>b</sup> Downgraded two levels dues to risk of bias and imprecision. <br/><sup>c</sup> Downgraded one level due to risk of bias and two levels due to imprecision. <br/><sup>d</sup> Downgraded one level due to risk of bias; however, this bias may skew results in favour of SCS. <br/><sup>e</sup> Downgraded one level due to risk of bias; however, this may bias results in favour of SCS. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Normothermic machine perfusion (NMP) compared with static cold storage (SCS) for preservation of livers prior to transplantation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/full#CD014685-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014685-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Overall participant survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.42, 1.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Donated following brain death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.26, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Donated following circulatory death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.41, 5.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Serious adverse events (90‐day follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.22, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Graft survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.23, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Donated following brain death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.18, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Donated following circulatory death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.18, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Ischaemic biliary complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.12, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Donated following brain death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.03, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Donated following circulatory death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.11, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Primary non‐function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>482</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.07, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Donated following brain death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.06, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Donated following circulatory death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Early allograft dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>482</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.23, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Donated following brain death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.16, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Donated following circulatory death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.26, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Adverse events considered non‐serious <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 4.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hypothermic oxygenated machine perfusion (HOPE) versus static cold storage (SCS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014685-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Normothermic machine perfusion (NMP) versus static cold storage (SCS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Overall participant survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.31, 3.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Graft survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.44, 3.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Ischaemic biliary complications (on protocol imaging) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.27, 2.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Early allograft dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>540</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.22, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Adverse events considered non‐serious <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.54, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Normothermic machine perfusion (NMP) versus static cold storage (SCS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#CD014685-tbl-0004">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-1"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 Overall participant survival</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.1.1 Donated following brain death</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Ravaioli 2022</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Electronic randomisation through Medidata Balance. Concealed until liver accepted. Well matched groups. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All participants received the intervention they were randomised to. Does not specify intention to treat, but as all livers randomised to each group received that intervention the ITT analysis would be identical to per‐protocol analysis. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data available for all/nearly all participants.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Hard outcome of patient survival.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Protocol available.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> <tr class="study-data"> <td> <p>Czigany 2021</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Well matched groups.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label trial due to nature of the intervention, but no bias arising from deviations from intended interventions. Intention to treat. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data available for all/nearly all participants.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Hard outcome of patient survival. Protocol explains outcome assessors blinded.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Pre‐published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> <tr class="study-data"> <td> <p>Schlegel 2023</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear description of randomisation process, concealment of block size and allocation concealment. There were baseline differences in the groups, but this was likely due to random chance and the relatively small sample size, rather than issues in the randomisation process. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Participants and treating physicians were blinded. Surgeons performing machine perfusion clearly not blinded. No deviations to treatments because of trial context. Intention to treat analysis used. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Complete outcome data with no loss to follow‐up.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Hard outcome of participant survival.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>This outcome was pre‐specified in the pre‐published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High quality randomised trial.</p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.1.2 Donated following circulatory death</b> </p> </td> </tr> <tr class="study-data"> <td> <p>van Rijn 2021</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated centralised randomisation. Well matched for all key factors.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Patients and procurement teams were blinded. Implanting teams could not be blinded. Intention to treat analysis applied. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data available for all/nearly all participants ‐ full description given in Figure S1 of their manuscript. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Hard outcome of patient death.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Prepublished protocol specified outcome.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 Overall participant survival</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-1">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-2"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.2 Serious adverse events (90‐day follow‐up)</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Czigany 2021</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Well matched groups.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label trial due to nature of the intervention, but no bias arising from deviations from intended interventions. Intention to treat. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data available on all/nearly all participants.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Pre‐specified Clavien‐Dindo with definitions. Protocol explains outcome assessors blinded. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Prespecified. Used the well validated Clavien Dindo greater than or equal to 3 with appropriate analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> <tr class="study-data"> <td> <p>Ravaioli 2022</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Electronic randomisation through Medidata Balance. Concealed until liver accepted. Well matched groups. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>All participants received the intervention they were randomised to. Does not specify intention to treat, but as all livers randomised to each group received that intervention the ITT analysis would be identical to per‐protocol analysis. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome available for all/nearly all participants.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Confirmed with study authors that values in Table 2 correspond to Clavien Dindo graded complications. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Protocol available. Used Clavien Dindo classification.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.2 Serious adverse events (90‐day follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-2">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-3"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.3 Graft survival</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.3.1 Donated following brain death</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Czigany 2021</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Well matched groups.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label trial due to nature of the intervention. No significant deviations from intended interventions. Intention‐to‐treat. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Full follow‐up to 1 year for most participants. 4 participants which were followed up to 6 months were appropriately censored. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear definitions of graft survival. Protocol explains outcome assessors blinded.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Prepublished protocol. Hard outcome of graft survival with appropriate definition and analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> <tr class="study-data"> <td> <p>Ravaioli 2022</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Electronic randomisation through Medidata Balance. Concealed until liver accepted. Well matched groups. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label due to nature of trial. All participants received the intervention they were randomised to. Does not specify intention to treat, but as all livers randomised to each group received that intervention the ITT analysis would be identical to per‐protocol analysis. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome data available for all/nearly all participants.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Hard outcome of graft survival with definition.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Protocol available. Pre‐specified analysing time‐to‐event with Kaplan‐Meier estimates.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> <tr class="study-data"> <td> <p>Schlegel 2023</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear description of randomisation process, concealment of block size and allocation concealment. There were baseline differences in the groups, but this was likely due to random chance and the relatively small sample size, rather than issues in the randomisation process. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No deviations to preservation technique because of trial context. Treating physicians blinded. Intention‐to‐treat analysis used. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Complete outcome data with no loss to follow‐up.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear objective definition of graft loss.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>This outcome was prespecified in the prepublished protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>We have included the prespecified overall graft loss in these graft survival analyses, rather than the post‐hoc 'liver‐specific' graft loss. </p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.3.2 Donated following circulatory death</b> </p> </td> </tr> <tr class="study-data"> <td> <p>van Rijn 2021</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated centralised randomisation. Well matched for all key factors.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Patients and procurement teams blinded. Implanting team blinding impossible. No significant deviations from intended interventions. Intention to treat. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Outcome data available for all/nearly all participants.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Death cencored graft survival with clear definition.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Prepublished protocol stating graft survival and definitions.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low risk of bias in every domain.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.3 Graft survival</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-3">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-4"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.4 Ischaemic biliary complications</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.4.1 Donated following brain death</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Schlegel 2023</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clear description of randomisation process, concealment of block size and allocation concealment. There were baseline differences in the groups, but this was likely due to random chance and the relatively small sample size, rather than issues in the randomisation process. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No deviations to preservation technique because of trial context. Treating physicians blinded and intention‐to‐treat analysis used. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Complete outcome data with no loss to follow‐up.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Non‐anastomotic strictures at 12 months' follow‐up. Radiologists assessing MRCP were blinded to treatment group. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>This outcome was prespecified in the prepublished protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High quality randomised trial.</p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.4.2 Donated following circulatory death</b> </p> </td> </tr> <tr class="study-data"> <td> <p>van Rijn 2021</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col12" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated centralised randomisation. Well matched for all key factors.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Participants and procurement teams blinded. Implanting team blinding impossible. No significant deviations from intended intervention. Intention to treat. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data available for all/nearly all participants.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Ischaemic cholangiopathy with clear definition. Review of scans by 2 blinded radiologists. Central blinded review of all clinical cases. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Prepublished protocol stating ischaemic cholangiopathy and definitions.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Clinically significant ischaemic cholangiopathy</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.4 Ischaemic biliary complications</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-4">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-5"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.7 Adverse events considered non‐serious</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Czigany 2021</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Well matched groups.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label trial due to nature of the intervention. No significant deviations. Intention to treat used. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data available for all participants</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Although protocol states that "Analysis of primary endpoints will be performed by an independent committee in a blinded fashion", it is likely that those actually recording all adverse events were aware of the treatment group. Knowledge of assignment to treatment group may have altered the decision to report an event as an adverse event. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Pre‐published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Although protocol states that "Analysis of primary endpoints will be performed by an independent committee in a blinded fashion", it is likely that those actually recording all adverse events were aware of the treatment group. Knowledge of assignment to treatment group may have altered the decision to report an event as an adverse event. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.7 Adverse events considered non‐serious</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-5">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-6"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.1 Overall participant survival</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Nasralla 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col6" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Similar donor characteristics between randomised livers. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label trial due to nature of interventions, but no significant deviations from intended intervention. Intention to treat performed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of patients were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Hard outcome of patient survival.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Pre‐specified Kaplan Meier estimates of 1‐year patient survival.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of patients were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.1 Overall participant survival</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-6">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-7"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.2 Graft survival</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Nasralla 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col6" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Similar donor characteristics between randomised livers. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label trial due to nature of interventions. No significant deviation from interventions. Intention to treat performed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of patients were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Hard outcome of graft survival with definition.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Pre‐specified Kaplan Meier estimates of 1‐year graft survival.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of patients were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> <tr class="study-data"> <td> <p>Markmann 2022</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Recipients were randomised. However, at the time of assessment of the liver in the donor, the implanting surgeon was aware of the assigned group and could decline the liver for transplantation at that stage. When being assessed in the donor (before retrieval of the liver), the implanting surgeon was significantly more likely to accept a DCD liver for a recipient who was randomised to NMP. Therefore, the baseline risk profile of donors was different, prior to initiation of NMP or SCS (significantly more DCD in the NMP group). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>When being assessed in the donor (before retrieval of the liver), the implanting surgeon was aware of the intended intervention. They were significantly more likely to accept a DCD liver for a recipient who was randomised to machine perfusion. Therefore, many higher risk DCD livers which were allocated to recipients randomised to SCS were never transplanted. The only analysis of graft survival which was presented was a per‐protocol analysis. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>For 1 year graft survival (98% for NMP and 99% for SCS) the numbers at risk at 1 year (eFigure 2) are 104 and 105 in NMP and SCS respectively. It is not clear how patients were lost to follow‐up. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Graft survival is not defined in the protocol or manuscript. It is not clear whether this is death censored. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No pre‐specified plan for how graft survival would be analysed. eFigure 2 contains a Logrank P value. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Recipients were randomised. However, at the time of assessment of the liver in the donor, the implanting surgeon was aware of the assigned group and could decline the liver for transplantation at that stage. </p> <p>When being assessed in the donor (before retrieval of the liver), the implanting surgeon was significantly more likely to accept a DCD liver for a recipient who was randomised to machine perfusion. Therefore, the baseline risk profile of donors was different, prior to initiation of NMP or SCS (significantly more DCD in the NMP group). </p> <p>The only analysis of graft survival which was presented was a per‐protocol analysis. Graft survival was not defined in the protocol or the manuscript, and it is unclear whether this was death censored. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.2 Graft survival</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-7">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-8"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.3 Ischaemic biliary complications (on protocol imaging)</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Nasralla 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col6" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Similar donor characteristics between randomised livers. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label trial due to nature of interventions. Minimal deviation from planned interventions. Intention to treat performed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of participants were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Prespecified outcome of NAS on MRCP (&gt; 70% of luminal diameter). Protocol MRCP. 2 independent blinded radiologists graded the MRCP. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Prespecified plan in the protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of patients were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.3 Ischaemic biliary complications (on protocol imaging)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-8">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-9"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.5 Adverse events considered non‐serious</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Nasralla 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col6" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Centralised electronic randomisation. Similar donor characteristics between randomised livers. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label trial due to nature of interventions. No significant deviation from intended interventions. Intention to treat performed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of patients were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>2 independent blinded clinicians assessed adverse events.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Pre‐specified analysis plan in the protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Unit of randomisation was the liver, but recipient outcomes are only available for transplanted grafts. A significantly higher proportion of patients were transplanted in the NMP group. It is unclear whether the extra grafts which were transplanted in the NMP group were lower quality grafts. This may mean grafts transplanted in the SCS were of a higher quality at baseline and therefore cause bias in favour of SCS for recipient outcomes. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.5 Adverse events considered non‐serious</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014685.pub2/references#riskOfBias2Table-9">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD014685.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD014685-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD014685-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD014685-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="id#CD014685-note-0011">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ko#CD014685-note-0007">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD014685-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD014685-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD014685-note-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD014685-note-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD014685-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014685\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014685\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014685\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014685\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014685\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=fw9sVDQH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014685.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD014685.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD014685.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD014685.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014685.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725809428"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD014685.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725809432"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD014685.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e844cecc1936d',t:'MTc0MDcyNTgwOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 